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ABSTRACT 
Mitochondria are a powerhouse for cells and a hub for numerous signaling pathways. Mitochondria 
are highly dynamic organelles, frequently changing their shape by shifting the balance of fusion and 
fission. Dysregulation in mitochondrial function or dynamics causes many human diseases. Among 
all mammalian organelles, mitochondria are unique organelles containing proteins encoded by two 
genomes. The sub-mitochondrial localization and biological function of 13 mitochondrial DNA 
(mtDNA)-encoded proteins have been clearly characterized, while many novel nuclear-encoded 
mitochondrial proteins are yet to be discovered. To comprehensively determine the mechanisms of 
mitochondrial-related diseases, it is imperative to reveal cellular functions of key mitochondrial 
proteins essential for mitochondrial biogenesis, structure, function, and dynamics. In this thesis, we 
have identified two novel nuclear-encoded mitochondrial proteins in mammalian cells: the Bin-
Amphiphysin-Rvs (BAR) protein FAM92A1 essential for regulation of mitochondrial membrane 
ultrastructure, and the guanosine triphosphate (GTP)-binding protein GTPBP8 required for 
mitochondrial translation. Due to the critical roles of mitochondria in cell signaling and cell survival, 
mitochondria, especially mitochondrial proteins, are the potential drug targets for treatment of a wide 
spectrum of diseases, including cancer. Thus, prickly zinc-doped copper oxide (Zn-CuO) 
nanoparticles (prickly NPs) are designed and synthesized for cancer therapy. Prickly NPs exhibit very 
effective antiproliferative capability, and the mechanism study shows that prickly NPs induce severe 
damages to mitochondria and the endoplasmic reticulum (ER), causing cancer cell death.   
In paper I, FAM92A1, as a novel BAR domain protein, localizes to the matrix side of the 
mitochondrial inner membrane (MIM) of U2OS cells through an N-terminal mitochondrial targeting 
sequence. Loss of FAM92A1 causes a severe disruption to mitochondrial morphology, ultrastructure, 
and membrane dynamics, impairing organelle bioenergetics. Furthermore, the purified recombinant 
FAM92A1 protein binds to model membranes through preferential binding to negatively charged 
phospholipids. After insertion into a lipid bilayer, FAM92A1 transforms spherical liposomes into 
narrow tubules, verifying its membrane-remodeling activity. Importantly, the aberrant mitochondrial 
morphology and function caused by depletion of FAM92A1 can be rescued by wild-type FAM92A1, 
but only partially rescued by the FAM92A1 mutants with defects in membrane binding and 
remodeling activity. In paper III, a novel GTP-binding protein GTPBP8 localizes to the mitochondrial 
matrix associated with the mitochondrial inner membrane of U2OS cells. The N-terminal 46aa is 
indispensable for the mitochondrial localization of GTPBP8. Importantly, GTPBP8 exclusively 
interacts with the large subunit of mitochondrial ribosome. Genetic knockdown of GTPBP8 causes a 
significant reduction in the level of mitoribosomes, inducing defects in mitochondrial translation and 
mitochondrial bioenergetics. In paper II, prickly NPs are synthesized and modified for optimal cancer 
targeting. The prickly NPs are very effective in inducing cell death of 3T3 and MCF-7 cancer cell 
lines. The prickly NPs efficiently accumulate in mitochondria, resulting in severe mechanic 
disruption to mitochondria and inducing cell apoptosis.  
Collectively, these studies reveal the biological functions of two previously uncharacterized 
mitochondrial proteins and an efficient nanoparticle cancer treatment by targeting mitochondria and 
ER of cancer cells. These new findings elucidate the crucial relation between mitochondrial form and 
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function, and hence, contribute to establishing the concept of membrane-mediated signaling in 
mitochondria. Furthermore, mitochondrial gene expression is critical for maintaining cellular 
homoeostasis. Therefore, the mitochondrial proteins and mitochondria per se are valuable potential 
drug targets for overcoming many mitochondrial diseases, including MELAS (mitochondrial 
myopathy, encephalopathy, lactic acidosis, strokes) syndrome, Parkinson disease, and cancer, among 
others. Taken together, this study elucidates the cellular functions of novel mitochondrial proteins 
and applies synthesized nanoparticles targeted to mitochondria for cancer treatment. The findings 
may open new avenues for developing novel therapeutics strategies for mitochondrial dysfunction-
linked human diseases. 
 REVIEW OF THE LITERATURE 
1. Introduction to mitochondria 
        Mitochondria are semi-autonomous organelles that contain their own genome and protein synthesis 
machinery. The most important function of mitochondria is adenosine triphosphate (ATP) generation 
through oxidative phosphorylation (OXPHOS), thereby regulating cellular metabolism in all 
eukaryotic cells (du Plessis et al. 2015). In addition to their role in energy conversion, mitochondria 
are also involved in a wide variety of critically important eukaryotic cellular processes, including 
apoptosis, iron-sulfur (Fe-S) cluster biosynthesis, fatty acid catabolism, lipids, quinone and steroid 
biosynthesis, Ca2+ homeostasis, amino acid and nucleotide metabolism, and regulation of cell 
signaling through reactive oxygen species (ROS), contributing to the development of metabolic 
disorders such as insulin resistance, diabetes and so on (Litvinova et al. 2015; Newman, He, and 
Verdin 2012). The pleotropic roles of mitochondria are matched by their morphological and 
ultrastructural complexity in response to different physiological conditions (Glytsou et al. 2016).  
Mitochondria form a dynamic tubular network that is dispersed throughout cells and subject to 
continuous rearrangements mediated by fusion and fission events. (Westermann 2010). The overall 
morphology and ultrastructure of mitochondria are determined by two membrane systems, the 
bordering outer membrane and the inner membrane that surrounds the central matrix space. This 
organization allows sub-compartmentalization of biochemical processes (Harner et al. 2014). 
Numerous proteins localized in the inner membrane are involved in maintaining the mitochondrial 
architecture. Aberrant mitochondrial forms and functions are widely accepted pathogenic 
mechanisms in a subset of human diseases, including cancer (Barrera et al. 2016), neurodegenerative 
disease (Johri and Beal 2012), diabetes (Sivitz and Yorek 2010), and cardiomyopathies (El-Hattab 
and Scaglia 2016).  
2. Mitochondrial origin  
Mitochondria originate from Gram-negative bacterial progenitors that were engulfed by a primordial 
eukaryotic “host” cell through endosymbiosis more than 1.5-2 billion years ago. Phylogenetic 
analysis of mitochondrial genes and their genomic organization and distribution indicate that all 
mitochondria derive from a common ancestral organelle, originating from the integration of a free-
living alphaproteobacteria into a host cell related to Asgard Archaea.  (Cavalier-Smith 2006; Dolezal 
et al. 2006; Dyall et al. 2004; Gross and Bhattacharya 2009). The class alphaproteobacteria 
encompasses well-defined diverse orders: the Rhizobiales, Rhodobacterales, Caulobacterales, 
Sphingomonadales, Pelagibacterales, Rhodospirillales, and Rickettsiales. Phylogenetic 
reconstruction suggests mitochondria as emerging either within, or as a sister group to, the 
Rickettsiales  (Lee, Taylor, and Millar 2013; Roger, Muñoz-Gómez, and Kamikawa 2017). Although 
all mitochondria in different species come from a common alphaproteobacterial ancestor, 
phylogenetic reconstructions based on mitochondrial DNA (mtDNA) sequences identified enormous 
variation in genome size, ranging from the tiny apicomplexan mtDNA (6 kbp) to the expansive plant 
mtDNA (>150 kbp) (S. Anderson et al. 1981). The complete size of human mtDNA is 16,569 base 
pairs. Despite divergent size, the coding function of mtDNA is relatively conserved. In general, 
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mtDNA in different species codes genes involved in mitochondrial translation apparatus, electron 
transport, and oxidative phosphorylation (Bullerwell and Gray 2004; Burger, Gray, and Lang 2003).   
How the proto-mitochondrial ancestor invaded and avoided elimination by the host has generated 
many hypotheses. Phylogenetic studies have found a number of ancestral bacterial genes to have been 
transferred to the nuclear genome, resulting in reduction and compaction of the mitochondrial genome. 
The combination of genomics, proteomics, and energy metabolism studies has suggested two 
fundamentally different endosymbiotic models for the origin of mitochondria. One model is the 
archezoan scenario: “the host of the proto-mitochondrial endosymbiont was amitochondrial 
eukaryote, termed archezoan” (Koonin 2010). The archezoan scenario most closely approximates the 
classical endosymbiont hypothesis of mitochondrial origin (Margulis 1970). The other model is the 
symbiogenesis scenario: “a single endosymbiotic event took place that involved the uptake of an -
proteobacterium by an archaeal cell leading to generation of mitochondria,” subsequently followed 
“by the evolution of the nucleus and compartmentalization of the eukaryotic cell” (Koonin 2010). 
The best example of the symbiogenesis scenario is the hydrogen hypothesis. The hydrogen hypothesis 
states that eukaryotes evolved through symbiotic association of an anaerobic, strictly hydrogen-
dependent, strictly autotrophic archaebacterium (the host) with a eubacterium (the symbiont) that was 
able to respire, but generated molecular hydrogen as a waste product of anaerobic heterotrophic 
metabolism. The host’s dependence upon molecular hydrogen produced by the symbiont is proposed 
to be the selective principle that forged the common ancestor of eukaryotic cells (Check 2012; Martin 
and Müller 1998). The fundamental difference between these two models of mitochondrial origin is 
whether the alpha-proteobacterial endosymbiosis that gave rise to the proto-mitochondria happened 
at the same time as and was integral to the formation of the eukaryotic cell (symbiogenesis scenario) 
or occurred subsequent to the formation of a primitive, amitochondriate cell that served as the host 
and that was already essentially eukaryotic (archezoan scenario) (Check 2012).  
Basing on the theory of endosymbiosis, much of the endosymbiont genome was gradually integrated 
into the nuclear chromosomes. However, the genome still maintains some of its ancestral features 
such as the double membrane, its own genetic material, and specific translation machinery (Check 
2012). The transition from endosymbiotic bacterium to permanent organelle entailed a massive 
number of evolutionary changes, including the origins of hundreds of new proteins and the 
corresponding import system, insertion of membrane transporters, integration of metabolism and 
reproduction, endosymbiotic gene transfer, lateral gene transfer, and the retargeting of proteins. All 
of these changes occurred incrementally as the endosymbiont and the host became integrated (Roger 
et al. 2017). 
3. Mitochondria as a target for cancer therapy  
Mitochondria exert both pivotal roles and lethal functions in physiological and pathological scenarios 
(Schimmer et al. 2008; Schmitt and Zischka 2018). On one hand, emerging studies have elucidated 
mitochondrial bioenergetics, biosynthesis, and signaling pathways to be essential for cancer cell 
growth, tumorigenesis, and metastasis (Feeley et al. 2015; Giampazolias and Tait 2016; Herst, Grasso, 
and Berridge 2018; Vyas, Zaganjor, and Haigis 2016). On the other hand, mitochondria are a suicidal 
weapon store for cells and dozens of cell death-involved signal transduction pathways converge on 
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mitochondria. This characteristic sensitizes them to drug treatment (Brian J. Altman, Zachary E. Stine, 
and Chi V. Dang 2016; Weinberg and Chandel 2015). In contrast to mitochondria of normal 
differentiated cells, the structure and function of mitochondria in cancer cells have changed markedly. 
For example, the metabolic pattern is reprogrammed, which primarily relies on aerobic glycolysis for 
satisfying energy and building block requirements of cancer cells (Heiden, Cantley, and Thompson 
2009; Liberti and Locasale 2016). Basing on these premises, a growing number of mitochondrial-
targeted compounds have been developed for efficient cancer therapy (Schmitt and Zischka 2018; 
Wallace 2012). So far, emerging compounds that induce the overproduction of ROS, increase the 
permeabilization of mitochondrial membrane, or reprogram mitochondrial metabolic pathway have 
acquired extraordinary efficacy in cancer therapy (Schmitt and Zischka 2018; Yang et al. 2016).  
Despite obvious efficiency in cancer therapy, many anticancer agents face challenges in clinical 
application such as diverse side-effects for patients, low bioavailability caused by multiple biological 
barriers, and absence of precise targeting (Carelle et al. 2002; Nussbaumer et al. 2011; Wise 2016). 
In addition, multiple drug resistance (MDR) further limits the application of anticancer drugs in 
clinical practice (Dean, Fojo, and Bates 2005; Krishna and Mayer 2000; Liu 2009). To overcome 
these limitations, multiple technologies have been explored to enhance the selective targeting of drugs 
and to improve the pharmacological and therapeutic properties of drugs administered parenterally 
(Allen and Cullis 2014; Angeli et al. 2008). Among the development methods, nanotechnology-based 
drug delivery systems (DDSs) have been widely used as drug carriers to promote preferential 
accumulation in cancer cells (Farokhzad and Langer 2009; Mirjalili, Soltani, and Chen 2012; 
Ravichandran 2009).  At present, several different types of nanoparticles (NPs), including polymeric 
NPs, polymeric micelles, dendrimers, liposomes, and nanocapsules, have been widely developed as 
vectors to assist the drugs in crossing biological barriers and specific barriers in tumors  (Figueiredo 
et al. 2018; Fontana et al. 2017; Marrache, Pathak, and Dhar 2014). 
The poor selectivity of the genotoxic agent cisplatin greatly limits its clinical applications (Duan et 
al. 2016). Thus, the hydrophobic mitochondria-targeted cisplatin prodrug Platin-M was synthesized 
and subsequently loaded into mitochondrial-targeted poly (lactic-co-glycolic acid)-β-poly (ethylene 
glycol) nanoparticles (PLGA-PEG NPs) used for the treatment of neuroblastoma cells. The results 
showed PLGA-PEG NPs efficiently deliver Platin-M to accumulate inside mitochondria of 
neuroblastoma cells, profoundly boosting the anticancer activity compared with cisplatin (Marrache 
et al. 2014). The chemotherapy medication Doxorubicin (DOX) induces nuclei and mitochondria 
damage through inhibiting the progression of topoisomerase II and increasing ROS, exhibiting great 
anticancer activity (Granados-Principal et al. 2010; Yang et al. 2014). However, free DOX always 
enters the nuclei of tumor cells rapidly without tarrying in the mitochondria, weakening the efficiency 
of DOX. Through embedding DOX into hyaluronic acid (HA)-modified hydroxyapatite (HAP) 
nanoparticles (HAP-HA), the HAP-HA nanoparticles efficiently and simultaneously deliver the DOX 
into both mitochondria and nuclei of tumor cells. The DOX/HAP-HA nanoparticles not only enhance 
the anticancer efficiency of DOX, but also exhibit good stability and favorable biocompatibility 
(Xiong et al. 2016).  
Altogether, an increasing number of studies demonstrate mitochondria to be a promising target for 
cancer therapy (Armstrong 2006; Schmitt and Zischka 2018, 2018; Weinberg and Chandel 2015). 
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Thus, a systematically understanding of the key pathophysiological differences between 
mitochondria in cancer cells and their counterparts in non-malignant cells will undoubtedly help us 
to develop novel drugs and to devise an optimal therapeutic strategy for cancer therapy in clinical 
practice.   
4. Mammalian mitochondrial ultrastructure  
Mitochondria possess two structurally and functionally distinct membranes, the relatively smooth 
outer membrane and the highly folded inner membrane, which encompass two separate aqueous 
compartments, the intermembrane space (IMS) and the mitochondrial matrix (Figure 1). The 
mitochondrial outer membrane (MOM) forms the envelope of the organelles that separates the 
mitochondrial compartments from the cytosol, whereas the mitochondrial inner membrane (MIM) is 
subdivided into the inner boundary membrane (IBM) and tubular or lamellar crista membrane (CM). 
The IBM that is adjacent to the MOM harbors many protein translocases, and the CM comprises 
invaginations of the MIM towards the matrix that enhances its surface and is important for 
mitochondrial function. Between the MOM and MIM is a small hydrophilic layer named the 
intermembrane space. The IMS is the site for many exciting biological processes. The matrix is 
surrounded by the MIM and houses the mitochondrial genome (Brandt et al., 2017; Freya & 
Mannellab, 2000; Logan, 2006; van der Laan, Horvath, & Pfanner, 2016)  
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Figure 1. Mitochondrial ultrastructure. (A) Immunofluorescence image of mitochondria in U2OS cells. Mitochondria 
were visualized using antibody against the outer membrane protein TOM20. (B) The transmission electron microscopy 
(TEM) of mitochondria in U2OS cells. The lower panel is a magnification of electron tomographic reconstructions of 
mitochondria in blue area. The outer membrane (purple), inner boundary membrane (yellow), and crista (green) were 
superimposed on the tomographic slice and viewed from the top and side.  
4.1 Mitochondrial outer membrane  
The MOM forms the border between mitochondria and the cytosol, controlling the exchange of 
material and signaling with other cellular compartments (Schorr and van der Laan 2018). Similar to 
the eukaryotic plasma membrane, the protein-to-phospholipid ratio of the MOM is around 1:1 by 
weight. The MOM contains large numbers of integral membrane proteins known as porins, e.g. the 
voltage-dependent anion channel (VDAC). These molecular channels and pores transport precursor 
proteins and small compounds across the outer membrane, which enables the communication 
between mitochondria and the cellular environment (Checchetto and Szabo 2018). The outer 
membrane also contains proteins that mediate several different cellular processes. The intrinsic 
apoptotic pathway is executed by mitochondrial outer membrane permeabilization (MOMP) under 
the control of proapoptotic BCL-2 family members (Martinou and Youle 2011).  
Pten-induced kinase 1 (PINK1) protein is a mitochondrial localized serine/threonine kinase. In 
healthy mitochondria, PINK1 is constitutively imported into the matrix depending on the import 
receptor, translocase of the MOM subunit of 70 kDa (TOM70) and translocase of the MIM (TIM) 
(Greene et al. 2012; Kato et al. 2013). In the damaged or aged mitochondria, PINK1 accumulates on 
the outer membrane, activating the cytosolic Parkin’s E3 ubiquitin ligase activity. Then, Parkin are 
recruited to dysfunctional mitochondria and ubiquitinate outer membrane proteins, inducing 
mitophagy, which ultimately leads to the elimination of defective mitochondria (Pickrell and Youle 
2015).  
Furthermore, mitochondrial outer membrane-bound dynamin-related proteins (DRPs), mitofusin 1 
(Mfn1) and mitofusin 2 (Mfn2), mediate the fusion of the MOM. The outer membrane also contains 
several adaptors of dynamin-related protein 1 (Drp1) that recruit Drp1 from the cytosol to the MOM. 
These proteins facilitate membrane remodeling and are involved in the fission of mitochondria 
through their ability to self-assemble and hydrolyze GTP (Friedman and Nunnari 2014). Some 
proteins on the MOM tether the organelle to other cellular membranes such as the ER. The 
mitochondria-ER contacts play important roles in lipid transport and calcium signaling (Klecker, 
Böckler, and Westermann 2014). All proteins on the MOM are synthesized on cytosolic ribosomes 
and contain internal targeting sequences. Distinct protein-targeting machineries mediate the insertion 
of these proteins into the mitochondrial outer membrane (Rapaport 2003). 
4.2 Mitochondrial intermembrane space  
The mitochondrial intermembrane space is a small hydrophilic layer between the outer membrane 
and the inner membrane. Due to the free diffusion of small molecules, such as glutathione, between 
the cytosol and the IMS, it forms a reducing environment. Among ~1500 mitochondrial proteins, the 
proteins in IMS constitute about 10% of the mitochondrial proteome and play crucial roles in the 
communication with the cytosol and other mitochondrial compartments, in the uptake of metabolites, 
lipids, or metal ions, and in the regulation and execution of apoptosis (Backes and Herrmann 2018). 
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Most IMS proteins lack presequence and instead utilize the IMS localized oxidoreductase Mia40, 
which facilitates their translocation across the outer membrane in a reaction that is coupled to the 
formation of disulfide bonds within the protein. This process requires neither ATP nor the 
mitochondrial membrane potential (ΔΨm) (MacPherson and Tokatlidis 2017).  
4.3 Mitochondrial inner membrane  
The mitochondrial inner membrane provides an extended, highly folded surface for selective 
transport and energy-coupling reactions. In addition, the highly folded inner membrane surface covers 
up to 50% of the total membrane area, which efficiently satisfies the accommodation of the oxidative 
phosphorylation subunits. Thus, the inner membrane is a protein-rich membrane with two domains 
differing in topology and protein composition (Figure 2) (van der Laan et al. 2016; Rampelt et al. 
2017; Schwerzmann et al. 1986). The IBM is adjacent to the outer membrane and hosts most 
machinery for protein import to the inner mitochondrial compartments. The tubular or lamellar-like 
crista membranes are the deep invaginations of the inner membrane that provide an extended 
membrane surface for accumulation of the OXPHOS complexes (Complex I, II, III, IV, and F1FO-
ATP synthase) (Gilkerson, Selker, and Capaldi 2003; Vogel et al. 2006; Zick, Rabl, and Reichert 
2009). Through the electron microscopic studies, the OXPHOS complexes were estimated to 
represent 80% of the total intrinsic protein mass of the mitochondrial inner membranes (IBM and 
crista) (Baoukina, Marrink, and Tieleman 2012). The estimated protein/lipid ratio of the inner 
membrane is highly around 75:25 (D et al. 1990; Simbeni et al. 1991).  
Crista membranes are connected to the IBM by narrow tubular or neck-like structures known as crista 
junctions (CJs) (Zick et al. 2009). The diameter of CJs is rather small, ranging from 12 to 40 nm 
(Nicastro et al. 2000; Perkins, Ellisman, and Fox 2003). The limited diameter maintains the 
asymmetric protein composition of the IBM and CM, and also efficiently acts as a dynamic diffusion 
barrier for movement proteins and metabolites between the intracristal space (ICS) and IMS and 
between the crista and IBM (Mannella et al. 1994; Rabl et al. 2009). The assembly and stabilization 
of the CJs structures mainly depend on the evolutionarily conserved mitochondrial contact site and 
cristae organizing system (MICOS) complex, a large and sophisticated inner membrane protein 
complex accumulated at CJs. The MICOS complex also establish contact sites between the inner and 
outer mitochondrial membranes by interacting with the outer membrane protein complexes (van der 
Laan et al. 2016; Pfanner et al. 2014; Wollweber, von der Malsburg, and van der Laan 2017). 
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Figure 2. Ultrastructure and representative proteins of the mitochondrial inner membrane. The inner membrane is 
sub-divided into the IBM and folded crista membranes. Protein translocases of the inner membrane 22 and 23 (TIM22 
and TIM23) are preferentially located in the IBM, whereas OXPHOS complexes (complex I, II, III, IV) and the F1Fo-
ATP synthase (complex V) are enriched in the CM. The IBM and crista are connected by CJs, where the MICOS complex 
and OPA1 are enriched. The MICOS and F1Fo-ATP synthase maintain the stabilization of CJs and crista, respectively. 
This picture is modified from van der Laan, Horvath, and Pfanner 2016. 
4.4 Matrix  
The matrix is one of the most densely packed portions of the cell. Proteins in matrix constitute up to 
50% of whole mitochondrial proteins (Goodsell 2010; Srere 1980). The matrix contains enzymes 
involved in such processes as the tricarboxylic acid cycle, oxidative phosphorylation, and beta 
oxidation of fatty acids. The entire set of mtDNA-encoded protein synthesis machinery is localized 
in the matrix, including mitochondrial DNA, polymerases, mitochondrial ribosomes, and transfer 
RNA (tRNA), among others. In addition, the folding and assembly of proteins derived from nuclear 
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and mitochondrial genomes are accomplished by the matrix-localized proteins, including the 
chaperonins heat shock protein 60 (HSP60) and HSP10, and chaperones including the HSP90 paralog 
tumor necrosis factor receptor-associated protein 1 (TRAP1) and the mitochondrial matrix 70 kDa 
heat shock protein (mtHSP70) (Kim et al. 2013; Xiwei Zheng, Cong Bi, Marissa Brooks 2015).  
Furthermore, the matrix acts as the main storage site for the  Ca2+  pool (Vais et al. 2016).  
5. Mitochondrial protein import pathways  
The mitochondrial proteome comprises approximately 1500 different proteins in mammals. Except 
for 13 core subunits of the respiratory chain encoded by mtDNA and synthesized in mitochondria, all 
other proteins are encoded by nuclear DNA and are synthesized as precursors in the cytosol (Hock 
and Kralli 2009). The unfolded precursors are subsequently imported into mitochondria via five major 
identified importing pathways depending on their mitochondrial targeting signals. Notably, each of 
the importing pathways is characterized by a different type of targeting signal (Schmidt, Pfanner, and 
Meisinger 2010; Wiedemann and Pfanner 2017).  
The common entry gate for most precursors is the translocase of the outer membrane (TOM) complex. 
After passing through the TOM complex, the precursors use five different pathways to finish the 
localization of the mitochondrial subcompartments (Chacinska et al. 2009; Wiedemann and Pfanner 
2017).  In addition, a number of outer membrane proteins with α-helical transmembrane segments 
localize to the mitochondrial outer membrane through the mitochondrial importing complex. 
5.1 Presequence pathway to the matrix and mitochondrial inner membrane  
The presequence pathway is a classical route of protein import, which mediates the translocation of 
the vast majority of matrix proteins and many inner membrane proteins. Proteins imported via the 
presequence pathway are characterized by a cleavable sequence at the N-terminus called the 
mitochondrial targeting sequence (MTS). The presequence functions as targeting signals and usually 
consists of 10-80 amino acid residues that have the potential to form amphipathic helices with one 
hydrophobic and one positively charged face (Abe et al. 2000; Roise et al. 1986; Vögtle et al. 2009).   
The cleavable presequence-carrying preproteins are transferred from the TOM complex to the TIM23 
protein translocator complex. The TIM23 complex comprises ten subunits, Tim50, Tim23, Tim17, 
Tim44, Tim14 (Pam18), Tim16 (Pam16), Tim21, Pam17, mtHsp70 and Mge1 (Chacinska et al. 2005; 
Mokranjac and Neupert 2015). During the translocase in the TIM23 complex, the precursors with 
hydrophobic sorting signals are laterally released into the mitochondrial inner membrane. For the 
matrix localized protein, the TIM23 complex in cooperation with presequence translocase-associated 
motor (PAM) forms TIM23-PAM complex, which mediates the transportation of precursors into the 
matrix (Straub et al. 2016). Then the mitochondrial membrane potential drives the translocation of 
the presequence through the TIM23 complex and ATP powers the chaperone mtHSP70 of PAM 
(Horst et al. 1997; Kang et al. 1990). Lastly, the amino-terminal presequence of the precursor will be 
cleaved by the mitochondrial processing peptidase (MPP) (Hawlitschek et al. 1988).  
5.2 Carrier pathway to the mitochondrial inner membrane  
Different from the precursors with an N-terminal cleavable presequence, the precursors translocated 
through the carrier pathway contain three to six uncleavable discontinuous internal targeting signals 
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(Chacinska et al. 2009; Saitoh et al. 2007; Wiedemann and Pfanner 2017). Because the precursors 
usually contain a multispanning hydrophobic structure, cytosolic localized chaperones (such as 
HSP70) often bind precursors to prevent their aggregation (Li et al. 2009; Young, Hoogenraad, and 
Hartl 2003; Zara et al. 2009). The formed complexes of the precursors and chaperones are then 
recruited to the receptor of mitochondrial outer membrane TOM70 which possesses binding sites for 
the precursors and chaperones (Li et al. 2009; Young et al. 2003). The interaction of TOM70 with 
the precursors further mediates the translocation of the precursors across the TOM complex, usually 
consisting of TOM40 (Wiedemann, Pfanner, and Ryan 2001). After being translocated through 
TOM40, the precursors are transferred by the TIM9-TIM10 chaperone through the intermembrane 
space (Curran et al. 2002; Webb et al. 2006). Then the precursor translocase of the inner membrane, 
the TIM22 complex, drives the membrane insertion of imported proteins in a ΔΨm dependent reaction 
(Lithgow and Schneider 2010; Wagner et al. 2008). 
5.3 Oxidative folding pathway of the intermembrane space 
Most intermembrane space proteins are small proteins that are synthesized without cleavable 
presequence but contain Cys motifs (Gabriel et al. 2007).  The precursors are imported by the TOM 
complex and the mitochondrial intermembrane space import and assembly (MIA) proteins 
(Chacinska et al. 2004a; Naoé et al. 2004). MIA includes the protein disulfide carrier Mia40 and the 
sulfhydryl oxidase Erv1 (essential for respiration and viability 1) (Allen et al. 2005; Chacinska et al. 
2004b; Terziyska et al. 2005). Erv1 oxidizes Mia40 by transferring a disulfide bond (S-S) to Mia40 
(Bien et al. 2010; Bihlmaier et al. 2007; Stojanovski et al. 2008). After translocation across the TOM 
complex, the precursor proteins bind to the oxidized Mia40 via forming a transient disulfide bond 
between the targeting signal of the precursor and Mia40 (Allen et al. 2005; Bihlmaier et al. 2007). 
Then, Mia40 transfers the disulfide bond to the precursor. Thus, Mia40 returns to the reduced form 
and is recyclced for further re-oxidized by Erv1. The oxidized precursor proteins are released to the 
mitochondrial intramembrane space (Stojanovski et al. 2008).  
5.4 β-barrel pathway of the mitochondrial outer membrane 
The mitochondrial outer membrane localized proteins contain two different types of integral proteins, 
α-helical proteins and β-barrel proteins (Schmidt et al. 2010; Wiedemann and Pfanner 2017). The two 
kinds of precursor proteins are sorted to the mitochondrial outer membrane through two different 
pathways (Wiedemann et al. 2003; Wiedemann and Pfanner 2017). Similar to the above protein 
import pathway, the β-barrel proteins are translocated to the mitochondrial outer membrane through 
the TOM complex (Ahting et al. 1999; Model et al. 2001; Paschen et al. 2003). Simply, the precursors 
of β-barrel proteins are initially imported by TOM complex. Then the transported precursors bind to 
small TIM chaperones existing in the intermembrane space. Lastly, the sorting and assembly 
machinery (SAM) facilitates the insertion of the precursor into the outer membrane (Chan and 
Lithgow 2008; Kozjak et al. 2003; Pfanner et al. 2004). The receptor TOM22 and the peripheral 
membrane protein Sam37 link TOM and SAM into a transient supercomplex that promotes the 
efficient transfer of precursor proteins (Meisinger et al. 2004; Wideman et al. 2010; Yamano, Tanaka-
Yamano, and Endo 2010). Folding of the β-barrel occurs at Sam50-Sam35, followed by release of 
the β-barrel into the lipid phase of the MOM (Wideman et al. 2010). 
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5.5 α-helical transmembrane proteins of the mitochondrial outer membrane  
The biogenesis of α-helical outer membrane proteins is less understand than the β-barrel proteins at 
present (Dukanovic and Rapaport 2011; Ellenrieder, Mårtensson, and Becker 2015). Three major 
protein classes are involved: signal-anchored proteins, tail-anchored proteins, and polytopic 
(multispanning) outer membrane proteins (Wiedemann and Pfanner 2017). Different import 
pathways mediate the sorting of these three integral outer membrane protein classes. For the part of 
polytopic MOM precursors, the proteins are recognized by TOM70 and are subsequently transferred 
to the insertase of the mitochondrial outer membrane, also known as MIM complex. The MIM 
complex promotes the efficient insertion of the polytopic proteins (Becker et al. 2011; Papić et al. 
2011). The other polytopic proteins as well as tail-anchored MOM proteins may be inserted into the 
outer membrane in a lipid-assisted manner, possibly independent of specific proteinaceous machinery 
(Kemper et al. 2008; Krumpe et al. 2012; Setoguchi, Otera, and Mihara 2006). Except for the 
polytopic proteins, the precursors of proteins with an N-terminal signal anchor sequence are also 
dependent on the MIM complex for insertion into the mitochondrial outer membrane (Wiedemann 
and Pfanner 2017).  
6. Formation and maintenance of crista  
The mitochondrial inner membrane is highly folded, having a four-fold greater surface area than the 
outer membrane (Frey and Mannella 2000; Mannella 2006). Depending on the degree of membrane 
curvature, the inner membrane is subdivided into different morphologically distinct domains: the 
unfolded or flat IBM, the curved tubular or flat lamellar crista membranes, and the highly curved 
crista junction and crista tip with negative membrane curvature and positive membrane curvature, 
respectively (Figure 3A) (van der Laan et al. 2016). The crista  structure can vary in length, width, 
lateral alignment, rigidity, and angularity (Mannella 2006; Zick et al. 2009). The inner boundary 
membrane is enriched for the import and assembly machinery for the mitochondrial proteome (Vogel 
et al. 2006). The crista membrane houses assembled electron transport chain protein complexes and 
ATP synthases, which efficiently couple the processes of oxidative phosphorylation and ATP 
generation. The narrow crista junction area helps to restrict proteins to a particular area of the inner 
membrane, e.g. the proaprototic factor cytochrome c is limited to the ICS to avoid activation of the 
apoptotic process (Friedman et al. 2015; Olichon et al. 2003). The dimerization of ademiosimie 
triphosphatases (ATPases) at the crista tip stabilizes crista membrane rims (Acehan et al. 2011; 
Daviesa et al. 2012).  
The morphology of crista varies in size and shape, appearing as flat lamellae, extended tubules or 
heterogeneous membrane sacs (Frey, Renken, and Perkins 2002; Mannella et al. 2002; Perkins et al. 
1997; Zick et al. 2009). Depending on the environmental state, the crista membranes usually undergo 
extensive changes such as increasing the abundance of the crista membrane, tightening between crista  
membranes, and opening of crista junction (Hackenbrock 1966). The mechanisms by which inner 
membrane domains are established and maintained are poorly understood at present, but several 
protein complexes and phospholipids have been found to mediate the biogenesis and maintenance of 
the sophisticated crista structure. The aberrant expression of three main protein complexes, optic 
atrophy 1 (OPA1), MICOS and ATP synthases, leads to aberrant crista morphology, suggesting 
pivotal roles in crista architecture (Figure 3B). Furthermore, the composition of the mitochondrial 
18 
 
lipid or the level of scaffolding proteins such as prohibitin are proposed to determine the inner 
membrane structure (Del Dotto et al. 2018; Ikon and Ryan 2017; Kozjak-Pavlovic 2017; Quintana-
cabrera et al. 2018; Zerbes et al. 2012; Zick, Rabl, and Reichert 2009). 
 
Figure 3. Protein complexes involved in characteristic morphology of crista. (A) Schematic representation with the 
main regulators of crista morphology positioned in crista. (B) Representative phenotypes resulting from the ablation of 
key regulators of crista structure. This picture is modified from Del Dotto et al. 2018. 
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6.1 OPA1  
OPA1 is a dynamin-related guanosine triphosphatase (GTPase) located in the inner membrane facing 
the intermembrane space. It governs the delicate balance between fusion and fission in the dynamic 
mitochondrial network. In addition, OPA1 is capable of forming oligomers or higher molecular 
weight complexes that are involved in crista structure organization (MacVicar and Langer 2016; 
Pernas and Scorrano 2016). Human OPA1 gene consists of 31 exons and results in synthesis of at 
least eight different messenger RNA (mRNA). The eight OPA1 transcripts encode proteins of 924-
1014 amino acids (Delettre et al. 2001). After being imported into mitochondria, OPA1 precursor 
proteins are processed by the MPP, producing the mitochondrial inner membrane-bound long form 
of OPA1 (L-OPA1). In humans, four L-OPA1 polypeptides contain both S1 and S2 proteolytic 
cleavage sites, whereas the other four polypeptides contain the S1 proteolytic site alone. The L-OPA1 
polypeptides are further processed by the inner membrane peptidases OMA1 and YME1L at the S1 
and S2 site, respectively. Proteolysis at these two sites results in loss of the transmembrane domain 
of L-OPA1, hence generating a soluble short form of OPA1 (S-OPA1).   
In healthy conditions, due to the limited OMA1 activity, mature OPA1 undergoes constitutive 
processing at S1 and S2, leading to the accumulation of noncleaved, long and short form of OPA1. 
The L-OPA1 and S-OPA1 assemble into oligomeric complexes and situates along the crista structure. 
The oligomeric complexes are indispensable for inter-crista membrane tethering and play key roles 
in maintaining crista ultrastructure (Frezza et al. 2006; Yamaguchi et al. 2008). In stress conditions 
or apoptotic stimulation, OMA1 is activated and causes the reduction of L-OPA1 and the increase of 
S-OPA1. The disturbance of the L-OPA1 and S-OPA1 balance further induces abnormal crista  
ultrastructure (MacVicar and Langer 2016).  Although S-OPA1 does not appear to play a key role in 
steady-state maintenance of crista morphology, increasing evidences suggests that it may play a role 
in crista stapling by increasing OPA1 oligomerization between apposing crista membranes 
(MacVicar and Langer 2016; Pellegrini and Scorrano 2007). 
6.2 MICOS complex 
The mitochondrial contact site and cristae organizing system also known as the MICOS complex are 
a large inner membrane complex of proteins localized in the crista junction that function in organizing 
the inner membrane into folds, which is crucial for determining crista structure and formation of crista 
junction (Daviesa et al. 2012; Muñoz-Gómez et al. 2015). Compared with the six identified subunits 
of the MICOS complex in yeast, the diversity of subunits and interactions seems much greater in the 
mammalian system. Eight subunits of MICOS (MIC60, MIC10, MIC19, MIC25, MIC23, MIC27, 
MIC13, and MIC14) and one putative interactor (DnaJC11) have thus far been identified as 
components of the MICOS complex, with possibly more to come (Alkhaja et al. 2012; An, Shi, He, 
Lui, Liu, Huang, and M Saeed Sheikh 2012; Darshi et al. 2011; Genin et al. 2016; Ioakeimidis et al. 
2014; Koob et al. 2015; Weber et al. 2013). Except for the two peripheral inner membrane subunits 
MIC25 and MIC14, the other subunits are embedded into the inner membrane with domains facing 
the intermembrane space. The depletion of a single subunit, especially the core components of the 
MICOS complex, MIC60 and MIC10, will lead to a reduction in the number of crista junction and a 
defect in lamellar crista shape (Harner et al. 2011; Hoppins et al. 2011; Rabl et al. 2009).  
The MICOS complex interacts with the outer membrane SAM complex. Together with the outer 
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membrane components metaxin1-3 and the full-length DnaJC11, the MICOS complex further forms 
a high molecular super-complex called the mitochondrial intermembrane space bridge (MIB) 
complex. Through the interaction of core subunit MIC60 with TOM, SAM and fusion protein Ugo1, 
and outer membrane protein porin (also known as VADC), the MIB complex efficiently couples the 
crista organization system with the mitochondrial import machineries (Harner et al. 2011; von der 
Malsburg et al. 2011; Xie et al. 2007).  
6.3 Dimeric ATP synthase 
The F1Fo-ATP synthase (ATP synthase) is a highly conserved rotary motor enzyme accomplishing 
the energy conversion in mitochondria. It is a multi-subunit assembly complex and consists of two 
structure domains, a matrix localized globular domain (F1) and an intrinsic membrane domain (Fo), 
linked together by a central stalk and a peripheral stalk (Jan Pieter Abrahams, Andrew G. W. Leslie 
1994; Walker and Dickson 2006). The process of ATP generation catalyzed by ATP synthase can be 
divided into three steps: (1) the inward passage of proton via Fo domain converts electrochemical 
proton gradient energy across the mitochondrial inner membrane into subunit rotation; (2) the rotating 
transmission device, the central stalk, rotates in a clockwise manner and transmits the energy to 
the catalytic sites of F1 domain; and (3) the catalytic sites convert mechanical energy of rotation into 
the chemical bond between the ADP-O and Pi, which synthesizes ATP (Jan Pieter Abrahams, Andrew 
G. W. Leslie 1994; Walker and Dickson 2006). 
Except for ATP generation, ATP synthase is observed to form dimers in rows along the highly curved 
crista ridge, which is involved in the biogenesis of the crista membrane (Davies et al. 2012; Gavin 
2004; Minauro-Sanmiguel, Wilkens, and Garcia 2005; Strauss et al. 2008). Electron cryotomography 
(cryoET) revealed that the mammalian ATP synthase is arranged in long ∼1 μm rows of dimeric 
super-complexes, located at the tip of crista membranes. The interface of the dimer is formed by 
contacts on both F1 and Fo domains and the dimer ribbons enforce a strong local curvature on the 
crista  membrane with a 17 nm outer radius (Strauss et al. 2008). The dimers form a V-shaped 
structure with an angle of 86° between monomers (Hahn et al. 2016). The two F1 subcomplexes 
within each dimer are consistently 28 nm apart, while the distance between adjacent dimers along the 
rows is variable among the different species (Davies et al. 2012). Deletion of the two accessory 
subunits that mediate the dimer formation leads to the loss of ATPase dimerization, consequently 
altering the crista architecture (Arselin et al., 2003).  
6.4 BAR domain protein 
The Bin-Amphiphysin-Rvs (BAR) domain family of proteins are central regulators of diverse cellular 
processes in all eukaryotes, characterized by their modular architecture. BAR domain proteins sense 
and interact with membranes via non-specific electrostatic interactions, sculpting phosphoinositide-
rich membranes and generating membrane curvature, invaginations (e.g. endocytosis), and protrusion 
(e.g. filopodia). According to their preferences for membranes of different curvatures, BAR domain 
proteins are classified into three major subfamilies: the classical crescent-shaped N-BAR (Peter et al. 
2004; Tarricone et al. 2001), the more extended and less curved Fes/CIP4 homology BAR (F-BAR) 
(Frost, De Camilli, and Unger 2007; Henne et al. 2007; Itoh et al. 2005), and the inverse curvature I-
BAR (Lee et al. 2007; Millard et al. 2005).  
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Most of identified N-BAR domain proteins contain an N-terminal amphipathic helix and prefer 
membranes of high positive curvature. F-BAR domain protein has a strong preference for positively 
curved membranes (Carman and Dominguez 2018; Saarikangas, Zhao, and Lappalainen 2010). In 
contrast to N-BAR and F-BAR domain proteins which induce the formation of membrane 
invagination, I-BAR domain proteins prefer to sense negatively curved membranes and help maintain 
membrane protrusion (Mattila et al. 2007). Except for BAR domain, most BAR domain proteins 
contain additional domains that often function together with the BAR domain in membrane binding 
and in protein-protein interactions. For example, the N-BAR domain protein endophilin contains one 
SH3 domain at the C-terminus, mediating the binding to the interaction proteins (Ringstad, Nemoto, 
and De Camilli 2002; Verstreken et al. 2003).  
At the structural level, the BAR domains are dimers of an antiparallel helix bundle that display 
varying degrees of intrinsic curvature (Peter et al. 2004; Shimada et al. 2007; Weissenhorn 2005). 
Furthermore, the BAR domains can oligomerize into helical scaffolds to promote membrane 
deformation (Carman and Dominguez 2018; Mim et al. 2012). In vitro studies, the purified BAR 
domain proteins were verified to sculpt membrane-like liposome into tubes and vesicles (Frost et al. 
2008; Peter et al. 2004). Furthermore, cryoET reconstruction has shown how the F-BAR domain 
protein generates membrane tubulation and visiculation (Frost et al. 2008). These studies suggest the 
essential roles of the BAR domain in dynamic membrane remodeling and in intracellular vesicle 
budding.   
Except for endocytosis, apoptosis, and cell-cell fusion, membrane scuplting is also required for crista  
membrane biogenesis and maintenance. At present, several proteins have also been verified to control 
crista morphology in addition to the above-introduced proteins (An, Shi, He, Lui, Liu, Huang, and M. 
Saeed Sheikh 2012; Guarani et al. 2015; John et al. 2005). So far, the BAR domain superfamily of 
proteins has mainly been identified to funcion in the endocyotic pathway; only one N-BAR domain 
protein FAM92A1 has been found to play a key role in maintenance of mitochondrial membrane 
structure, especially mitochondrial inner membrane architecture (Wang et al. 2019).  
7. Mitochondrial dynamics 
Mitochondria are highly dynamic organelle constantly undergoing fission and fusion, referred to as 
‘mitochondrial dynamics’. Through coordinate cycles of fusion and fission, mitochondria maintain 
their shape, distribution, and size (Tilokani et al. 2018; Westermann 2010). These processes are 
crucial for mitochondrial inheritance and for many cellular processes such as cell cycle, immunity, 
apoptosis and mitochondrial quality control. Furthermore, the frequently and rapidly dynamic process 
also allows for a transfer of information via exchange of mtDNA, proteins, lipids, and metabolites 
(Balaban, Nemoto, and Finkel 2005; Chen, Chomyn, and Chan 2005; Chen, McCaffery, and Chan 
2007; Frank et al. 2001; Ishihara et al. 2009; Tilokani et al. 2018; Westermann 2010) (Figure 4).  
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Figure 4. Physiological roles of mitochondrial dynamics. The biological function of mitochondrial fusion and fission. 
Fusion process is important for the dissipation of metabolic energy and defense of aging. Fission is required for 
inheritance and partitioning of mitochondria during cell division. Mitochondria division process also participates in 
intrinsic apoptosis through the release of cytochrome c from intracristal space to cytosol. Furthermore, mitochondria with 
low membrane potential or reduced OPA1 level after fission are prone to removal by the selectively mitochondrial 
autophagy, mitophagy. This picture is modified from Westermann 2010. 
The core machinery of dynamic transitions is mainly executed by highly conserved large GTPases 
belonging to the Dynamin family, with Drp1 and mitofusins (Mfn1/2) separately controlling fission 
and fusion of the MOM. In addition to the fusion of the MOM, another GTPase, OPA1, mediates the 
fusion of the mitochondrial inner membrane (Chan 2006a; Chang and Blackstone 2010; Suen, Norris, 
and Youle 2008).  
7.1 Mitochondrial fission  
Mitochondrial fission requires the coordination of cytoplasmic, cytoskeleton and organellar elements. 
The fission process consists of three key steps: (1)  the ER marks the mitochondrial pre-constricted 
fission site on the mitochondria after undergoing stimulation of fission signals; (2) the cytosolic 
localized inactive form of Drp1 is recruited around the marked fission sites and assembled into a 
spiral-shaped superstructure; (3) the higher-order assembled Drp1 leads to membrane constriction 
and induces the recruitment of Dynamin 2 (Dyn2) to accomplish the membrane scission through 
hydrolyzing GTP (Figure 5A) (Loson et al. 2013; Otera, Ishihara, and Mihara 2013; Tilokani et al. 
2018). 
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The mitochondrial pre-constricted fission sites usually occur at the contact sites between 
mitochondria and ER (Friedman et al. 2011). The ER-localized inverted formin 2 (INF2) and 
mitochondrial anchored formin-binding Spire 1C induce actin polymerization through the 
recruitment of myosin II at the ER-mitochondrial interface. The recruitment of myosin II provides 
the mechanical force for the actin cable, which drives the constriction of the mitochondrial membrane. 
With the decrease of mitochondrial diameter, the cytosolic Drp1 is recruited to the mitochondrial 
outer membrane via its adaptors. 
In mammals, four integral mitochondrial outer membrane adaptors are responsible for the recruitment 
of Drp1: mitochondrial fission protein 1 (Fis1), mitochondrial fission factor (Mff), and mitochondrial 
dynamics proteins of 49 and 51 kDa (MiD49 and MiD51) (Loson et al. 2013). The recruited Drp1 
proteins are subsequently oligomerized into a ring-like structure around the pre-constriction site. The 
GTP hydrolysis depending on GTPase activity of Drp1 leads to a conformational change, enhancing 
pre-existing mitochondrial constriction (Pernas and Scorrano 2016).   
Although Drp1 has roles in mitochondrial membrane constriction, Drp1 is unable to terminate fission 
alone. A recent study showed that another GTPase protein Dyn2 is recruited to the Drp1-mediated 
mitochondrial constriction neck. The assembled Dyn2 terminates membrane scission, leading to the 
formation of two daughter mitochondria (Lee et al. 2016).  
7.2 Mitochondrial fusion  
Fusion is an adaptation to intracellular life, facilitating communication between the mitochondria and 
host cell. Unlike the fission process, the fusion of mitochondrial outer and inner membrane are 
executed by different proteins (Chan 2006b; Lee and Yoon 2016). Globally, it is characterized by 
four different steps: (1) The two closely contacted mitochondria are tethered together through the 
insertion of dynamin-related MOM proteins Mfn1 and Mfn2 into the apposing MOM; (2) The dimeric 
conformational change of mitofusin shortens the distance between two mitochondria, leading to an 
increase in the contact surface of two membranes (Brandt et al. 2016; Ishihara 2004; Koltzscher et al. 
2003); (3) GTPase-dependent power stroke or GTP-dependent oligomerization mediates the fusion 
of the outer membrane. Following the MOM fusion, the L-OPA1 interacts with cardiolipin (CL), 
forming complexes, and the S-OPA1 stimulates GTPase activity or triggers structural rearrangements, 
promoting the fusion of mitochondrial inner membrane; (4) The oligomerized OPA1 coordinates with 
Mfn1 driving fusion of the inner membrane depending on GTP hydrolysis (Figure 5B) (Cipolat et al. 
2004; Mishra et al. 2014). 
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Figure 5. A schematic of mitochondrial fission and fusion. (A) Representative process of fission. Briefly, mark the 
mitochondrial pre-constriction site by ER, recruit the cytosolic localized Drp1 to the marked site, and assemble into a 
ring-like structure, mediating the pre-constriction of the membrane. Then, the polymerization of Myosin IIa at the 
mitochondrial-ER contact site provides the mechanical force for Drp1-mediated constriction. Lastly, Dyn2 is recruited to 
the constriction neck where it assembles and terminates membrane scission leading to two daughter mitochondria. (B) 
Representative process of fusion. The mitofusions tether the outer membrane of two opposing mitochondria, where the 
conformational change mediated by GTP hydrolysis increases the contact site. Then, GTP-dependent oligomerization 
induces the fusion of the outer membrane. Following the MOM fusion, OPA1 and cardiolipin drive fusion of the inner 
membrane. This picture is modified from Tilokani et al. 2018. 
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8. Mitochondrial DNA 
In mammalian cells, approximately 3-5% of total proteins are mitochondrial localized proteins. The 
vast majority are encoded by the nucleus genome, translated by the cytosolic ribosomes, and 
transported into mitochondria mediated by different importing mechanisms depending on the sub-
mitochondrial localization (Hoogenraad and Ryan 2007). Only 13 proteins, the necessary subunits of 
the OXPHOS complexes, are encoded by mitochondrial DNA and translated by mitochondrial 
ribosomes (mitoribosomes).  
8.1 mtDNA structure 
Mitochondrial DNA of mammals is a closed circular double-strand molecule of approximately 16.5 
kb that encodes for 37 genes (Shoubridge & Wai, 2007; Spelbrink, 2010). Except for the necessary 
subunits of OXPHOS complexes, mtDNA also encodes all of the 24 RNA components, including 22 
tRNA and 2 ribosomal RNA (rRNA) required for mitochondrial-encoded protein synthesis (Figure 
6). (Anderson, Bankier, Barrell, de Bruijn, et al., 1981; Clayton, 2000; Park & Larsson, 2011).  Due 
to a bias distribution of guanines between the two helical strands, the two strands of mtDNA are 
separated into a heavy strand (H-strand, black color in Figure 6) and a light strand (L-strand, red 
color in Figure 6) based on density difference in alkaline CsCl2 gradients (Clayton 2003). The coding 
genes distribute unevenly between H-strand and L-strand. The transcripts of L-strand contain 8 
tRNAs (P, E, S, Y, C, N, A, Q) and 1 mRNA of ND6. While the transcripts of H-strand are more 
numerous than those of the transcript of L-strand, including 2 rRNAs (12S and 16S), 14 tRNAs (F, 
V, L, I, M, W, D, K, G, R, H, S, L, T) and 10 mRNAs of polypeptides (ND1, ND2, ND3, ND4, ND4L, 
ND5, CYTB, COI, COII, COIII, ATP6 and ATP8) (Clayton, 2000; Taanman, 1999).  
Furthermore, the mtDNA contains one hallmark non-coding region with a size of 1124 bp called the 
D-loop region. It contains essential replication and transcription elements, thus acting as a promoter 
for both H-strand and L-strand at the initial step of the transcription process. The D-loop region is a 
hot spot for mtDNA alterations, and it contains two hypervariable regions (HV1 at positions 16024-
16383 and HV2 at positions 57-372) (Clayton 2000). The mutation of this region serves as a potential 
sensor for cellular DNA damage and a marker for disease development (Cai et al. 2011; Lee et al. 
2004).  Furthermore, the mutations of several regions of mtDNA D-loop region have been identified 
in breast cancer tissue (Richard et al. 2000; Tan, Bai, and Wong 2002).   
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Figure 6. Schematic structure of human mtDNA. The genomic organization and structural features of human mtDNA 
are depicted in a circular genomic map. The D-loop regulatory region is expanded and shown above. The 13 mtDNA-
encoded protein regions are marked in protein abbreviations. The tRNA genes are denoted by the single-letter amino acid 
code. The light-strand promotor and heavy-strand promotor are shown with LSP and HSP, respectively. The origin of H-
strand replication (OH) and L-strand replication (OL) are also indicated in brown. This picture is modified from Kelly and 
Scarpulla et al. 2004. 
8.2 Replication of mtDNA 
Over the past several decades, numerous efforts have been made to examine the model of mtDNA 
replication and transcription. So far, among the proposed mtDNA replication mechanisms, there are 
two main patterns, strand-displacement replication model (Clayton 1982) and strand-coupled 
replication model (Holt, Lorimer, and Jacobs 2000; Yang et al. 2002). In the study of Holt et al., the 
authors found the replication intermediates coexist in both human and mouse mitochondria (Holt et 
al. 2000). In the strand-coupled replication model, closed circular mtDNA begins leading-strand 
synthesis for the synthesis of lagging-strand early in replication. The synthesized lagging-strand 
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replication initiates at multiple sites, probably involving discontinuous synthesis of multiple short-
fragments (‘Okazaki’). 
Another asymmetric, the strand-displacement model (SDM) is a another model of mtDNA replication 
(Clayton 1991). Different from the strand-coupled replication model, the mtDNA synthesis occurs 
continuously on both strands basing on the SDM. Therefore, in order to ensure coordination of DNA 
synthesis, mtDNA contains a dedicated origin of DNA replication on each strand, the heavy-strand 
origin (OH) and the light-strand origin (OL) (Figure 6). Many replication factors are involved in the 
replication process. The core replicative polymerase-γ (POLγ) is the only DNA polymerase executing 
mtDNA replication (Fan et al. 2006; Gray and Tai Wai Wong 1992). Because POLγ cannot directly 
use double-strand DNA as a template on its own, mitochondrial single-stranded DNA (ssDNA)-
binding protein (mtSSB) stimulates DNA helicase TWINKLE to unwind the mtDNA duplex by 
working together with POLγ at the replication fork (Korhonen et al. 2004). The produced long 
stretches of ssDNA are stabilized by tetramerization of mtSSB (Kaguni 2004; Korhonen, Gaspari, 
and Falkenberg 2003). Furthermore, mitochondrial DNA-directed RNA polymerase POLRMT 
(mitochondrial RNA polymerase) mediates the synthesis of short primers and initiates nascent L-
strand mtDNA synthesis (Schwinghammer et al. 2013).   
In the strand-displacement replication model, the molecular mechanisms of the mtDNA replicative 
process are simply divided into four steps (Figure 7): (1) the replisome formed by POLγ and 
TWINKLE synthesizes nascent H-strand after initiation at the OH. The parental unwinded H-strand 
is stabilized by mtSSB (Figure 7A); (2) a stem-loop structure is formed when the H-strand replication 
passes through the OL region. POLRMT binds to the stem-loop structure and synthesizes short 
primers that initiate the synthesis of the nascent L-strand (Figure 7B); (3) POLγ synthesizes the 
nascent L-strand and H-strand separately using parental H-strand and L-strand as a template (Figure 
7C); (4) replication is terminated at either the OH or OL site after completion of both nascent strands 
(Figure 7D) (Bogenhagen and Clayton 2003; Bowmaker et al. 2003; Clayton 1982, 2003).  
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Figure 7. Replication process of mtDNA based on the strand-displacement replication model. (A) POLγ (green) and 
TWINKLE (orange) form the replisome and undirectionally synthesize the nascent H-strand. (B and C) The parent H-
strand forms a stem-loop structure and POLRMT (light teal) synthesizes short primers (yellow) that initiates the synthesis 
of nascent L-strand by POLγ. (D) The synthesis of the nascent strand (dotted line) is terminated when the initial site of 
replication is encountered. This picture is modified from (Shadel 2008) 
9. mtDNA-encoded gene expression 
Similar to nuclear-encoded gene expression, the process of mtDNA-encoded gene expression 
comprises transcription, assembly of mitoribosomes, translation, and MIM insertion of nascent 
polypeptides (Pearce et al., 2017; Rackham, Mercer, & Filipovska, 2012) (Figure 8). However, 
except for tRNA and rRNA, all enzymes required for mtDNA-encoded gene expression, subunits of 
mitoribosomes and the corresponding assembly factors are synthesized in the cytosol and imported 
into the matrix. Therefore, the whole process of mtDNA-encoded gene expression is controlled by 
dual gene expression systems. The precise regulation of gene synthesis and degradation of mtDNA-
encoded RNAs determine the steady-state levels of mtDNA-encoded proteins. The fine quality 
control of mtDNA-encoded gene expression enables cells to adapt to various environments and 
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produces the necessary energy. Defects in mtDNA-encoded gene expression damage the assembly of 
respiratory chain complexes, which reduces ATP production and causes a multi-system disease 
phenotype, predominantly affecting muscular and neuronal tissues (D’Souza and Minczuk 2018).  
 
Figure 8. Overview of human mtDNA-encoded gene expression. The main proteins involving in mtDNA-encoded 
gene expression are listed in each process. This picture is modified from Souza and Minczuk 2018; Kayal, Bentlage, et 
al 2016; Rackham and Mercer et al 2012.  
9.1 Transcription of mtDNA 
Transcription of the mitochondrial genome starts at the L-strand promoter (LSP) and H-strand 
promoter (HSP) in the D-loop region. At the initial step of transcription, the mitochondrial 
transcription factor A (TFAM) binds to the transcription site and introduces a 1800 bend in mtDNA 
(Campbell, Kolesar, and Kaufman 2012; Kanki and Ohgaki 2004). Then the DNA-dependent RNA 
polymerase POLRMT interacts with DNA around the transcription site and with the upstream region 
of the TFAM-binding site. The interaction of POLRMT with mtDNA induces the conformation 
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change of POLRMT, which assembles the mitochondrial transcription factor B2 (TFB2M) and forms 
an initiation complex (McCulloch, Seidel-Rogol, and Shadel 2002; Posse and Gustafsson 2017). The 
initiation complex induces opening of the promotor and synthesizes RNA. The mitochondrial 
transcription elongation factor (TEFM) is required for the elongation of transcription via interacting 
with the catalytic C-terminal part of POLRMT (Schwinghammer et al. 2013). After accomplishing 
transcription, the mitochondrial termination of factor 1 (MTERF1) bends the mtDNA and mediates 
transcription termination through base flipping and DNA unwinding (Jiménez-Menéndez et al. 2010; 
Yakubovskaya et al. 2010). The mt-mRNA and mt-rRNA sequences are separated from the primary 
transcripts through excision of mt-tRNA performed by RNAase P and RNase Z at the 5’- and 3’-end, 
respectively (S Anderson et al. 1981; Holzmann et al. 2008; Ojala, Montoya, and Attardi 1981).  
9.2 Translation of mtDNA-encoded proteins  
9.2.1 Assembly of mitochondrial ribosomes 
All polypeptides are translated in the ribosome using the mRNA as a template. Consistent with the 
cytosolic ribosome, the mature mitochondrial ribosomes comprise large ribonucleoprotein complexes 
composed of a large subunit (mt-LSU) and a small subunit (mt-SSU). The mt-SSU binds mRNA and 
translates the encoded message by selecting cognate aminoacyl-tRNA molecules (Ogle et al. 2001; 
Schmeing and Ramakrishnan 2009). The mt-LSU catalyzes the formation of peptide bonds through 
its polytidyl transferase center (PTC), thereby polymerizing the amino acids into a polypeptide chain 
(Ban 2000; Beringer and Rodnina 2007; Polikanov, Steitz, and Innis 2014). The mt-LSU also contains 
an exit tunnel that allows the newly synthesized polypeptides to leave the mitoribosomes (Jenni and 
Ban 2003; Kramer et al. 2009). Even though the mitochondrial ribosome is evolutionarily derived 
from the bacterial ribosome, mitoribosome has strongly diverged from its ancestral bacterial ribosome 
in terms of function, structure, rRNA and nucleoprotein composition. For example, the mitochondrial 
ribosome has half the length of rRNA and 36 additional nucleoproteins in comparison with the 
bacterial ribosome (Greber and Ban 2016; Jenni and Ban 2003; Sharma et al. 2003).  
Mammalian mitoribosomes sediment as a 55S particle, which consists of a 28S mt-SSU and a 39S 
mt-LSU. The mt-SSU is formed by a 12S rRNA and 30 mitochondrial ribosomal proteins (MRPs) 
and mt-LSU is formed by a 16S rRNA and 52 MRPs (Greber and Ban 2016). All mt-rRNAs are 
transcript from mtDNA genes, while all 82 MRPs are nuclear gene-encoded proteins. Therefore, 
MPRs are synthesized in the cytosolic ribosome and imported into mitochondria during the 
mitoribosomal assembly process. Except for the assembly of nucleoproteins, the mt-rRNA undergoes 
post-transcriptional processing for the maturation of mitoribosomes (Greber and Ban 2016). The 
pivotal roles of mitochondrial translation for cellular energy hemostasis, biogenesis, maintenance and 
regulation of the complex mitochondrial translation apparatus are poorly understood. This is 
particularly the case regarding how the MRPs are sequentially assembled to form macromolecular 
structures and what proteins or cell signaling are involved in the biogenesis process. To date, only a 
handful of mitoribosomal biogenetic factors, rRNA modifying enzymes, RNA helicases, and 
GTPases, have been identified. They are transiently associated with immature mitoribosomal subunits 
and promote processing, modification, and stability of rRNAs and ribosomal proteins for the 
formation of ribonucleoprotein particles (Figure 9) (Barrientos, 2015; Bogenhagen, Martin, & Koller, 
2014; S. S. Chen & Williamson, 2013). 
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In mammalian mitochondria, modification of rRNA is a necessary step for mitoribosomal biogenesis. 
Mitochondrial transcription factor B (TFB1M) is a methyltransferase-mediated dimethylation of two 
highly conserved adenosines at the 3’-end of mitochondrial 12S rRNA. This process is necessary for 
assembly of the mt-SSU (Metodiev et al. 2009). Another mitochondrial rRNA methyltransferase, 
NSUN4, methylates C911 in 12S rRNA, performing a key task in creating mature, functional 
mitoribosome (Metodiev et al. 2014a).  
For the biogenesis of the mitoribosomal large subunit, several proteins have been identified in the 
assembly process. The Asp-Glu-Ala-Asp (DEAD)-box protein DDX28 promotes mt-LSU biogenesis 
at the early stages through interacting with 16S rRNA and the mt-LSU (Tu and Barrientos 2015a). 
The mitochondrial GTPase 1 and 2 (MTG1/GTPBP7) bind to the 16S rRNA to facilitate incorporation 
of late-assembly proteins. Through coupling of mt-LSU assembly with intersubunit bridge formation, 
MTG1 controls mitochondrial translation (Kim and Barrientos 2018). Furthermore, another two 
GTPases, MTG2/GTPBP5 and GTPBP10, are specifically associated with the mitoribosomal large 
subunit at a late maturation state (Hirano et al. 2006; Lavdovskaia et al. 2018; Maiti et al. 2018). In 
addition, the domain of unknown function 143 (DUF143) family protein C7orf30 interacts with the 
uL14m, promoting uL14m incorporation into mt-LSU, hence sustaining mitochondrial translation 
(Rorbach, Gammage, and Minczuk 2012; Wanschers et al. 2012).   
For the assembly of mt-SSU, the mitochondrial GTPase C4orf14 is involved in the biogenesis of mt-
SSU via an interaction with the mitochondrial nucleoid (He et al. 2012). GTP-binding protein ERAL1 
is a mitochondrial RNA chaperone involved in the assembly of the 28S mt-SSU. Loss of ERAL1 
leads to decreased mitochondrial translation, causing redistribution of mitoribosomal small subunits 
and reduced 12S rRNA (Dennerlein, Rozanska, Wydro, Zofia M. A. Chrzanowska-Lightowlers, et al. 
2010; Uchiumi et al. 2010). 
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Figure 9.  A schematic overview of mammalian mitochondrial ribosome assembly. Only some representative 
ribosomal assembly factors are shown in the pictures. The assembly stage at which they act is depicted only approximately. 
This picture is modified from De Silva et al. 2015.  
9.2.1.1 rRNA-modifying enzymes 
The modification of rRNA at the conserved region, usually in the catalytic domain, is a key step in 
ribosome assembly. These modifications can happen co-transcriptionally, immediately after 
transcription, or during the pre-ribosomal particle assembly process (Venema and Tollervey 1999). 
Compared with more than 30 rRNA modifications in the prokaryotic ribosome and 200 rRNA 
modifications in the eukaryotic cytoplasmic ribosome, the mitochondrial rRNA has scarcely been 
modified. Until now, there are three major types of rRNA modifications in mammalian mitochondria: 
pseudouridylation, base methylation, and 2’-O-ribose methylation (De Silva et al. 2015).  
Although the enzyme responsible for pseudouridylated modification has not been identified to date, 
the human 16S rRNA has one pseudouridylated base at U1397 according to human 16S rRNA 
numbering (Motorin and Helm 2011). In mammalian mitochondria, methylation via specific 
methyltransferase (MTase) is the common type of rRNA modification (Motorin and Helm 2011). 
NSUN4 is a mitochondrial cytosine MTase that methylates cytosine 911 in 12S rRNA of the mt-SSU. 
In addition, NSUN4 also forms a complex with MTERF4 which is required to assemble the mt-LSU 
and mt-SSU (Cámara et al. 2011; Metodiev et al. 2014b). For 2’-O-ribose methylation, there are three 
sites in 16S rRNA of the mt-LSU that are modified by three methyltransferases, mitochondrial 
rRNA methyltransferase 1(MRM1), MRM2 and RMTL1 (also called MRM3). MRM1 catalyzes Gm 
residues at Gm1145. MRM2 and RMTL1 separately catalyze Um1369 and Gm1370, respectively, 
which lie in the A-loop of 16S rRNA (Lee and Bogenhagen 2014). Depletion of some of these rRNA-
modifying enzymes leads to defective biogenesis of the mitoribosome, and consequently, to a 
deficiency in mtDNA-encoded protein level (Rorbach et al. 2014).  
9.2.1.2 RNA helicases 
RNA helicases have a structurally conserved helicase core containing characteristic sequence 
elements and structural motifs. These proteins bind and remodel RNA and RNA-protein complex 
(RNP) in an ATP- or NTP-dependent manner. The DEAD-box proteins belong to superfamily 2 RNA 
helicase and are commonly involved in RNA-mediated processes, RNA folding steps, RNA 
conformational transitions, and among others. The DEAD-box proteins were named based on the 
unique amino acid sequence Asp-Glu-Ala-Asp in the motif II. Unlike the conventional RNA helicases 
which unwind helices by translocating along one of the strands and have high processivity, the 
DEAD-box helicases unwind duplexes and remodel RNA-protein complexes locally within the 
strands and have very low processivity (Pan and Russell 2010). DDX28 is one of recently identified 
DEAD-box proteins that is essential for 16S rRNA stability during the early stage of mt-LSU 
biogenesis (Tu and Barrientos 2015b). Another RNA helicase, DHX30, is involved in all stages of 
mitoribosomal assembly due to extensive interaction with mt-LSU, mt-SSU, and monosomes 
(Antonicka and Shoubridge 2015a).   
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9.2.1.3 GTPases 
GTPases are the members of the G-protein superfamily, which is a key regulator of many cellular 
processes (Hall 1998; Just and Peränen 2016). Through hydrolyzing GTP, GTPases act as a major 
signaling mechanism involved in many critical functions, such as translation of mRNA, cell cycling, 
and cell division (Sprang 1997; Vetter and Wittinghofer 2001). The structure of the GTP-binding 
domain of all GTPases are evolutionarily conserved. The GTP-binding domain is composed of 4-5 
highly conserved motifs (G1-G5), which form a characteristic fold (Pan and Russell 2010). GTPases 
play pivotal roles in the mitoribosomal assembly process (Nomura 1973; De Silva et al. 2015). 
Two GTP-binding proteins, GTPBP5 and GTPBP7, localize to the matrix side of the mitochondrial 
inner membrane. GTPBP7 also known as Mtg1specifically binds to the premature large subunit of 
the mitochondrial ribosome in a GTP-dependent manner and is released from the mature mt-LSU 
(Kotani et al. 2013a). The mt-LSU stimulates the GTPase activity of GTPBP7. The depletion of 
GTPBP7 reduces the overall mitochondrial translation activity and leads to the defects in the 
formation of respiratory complexes. GTPBP5 also known as ObgH1 belongs to the Obg family 
specifically associated with the mitoribosomal large subunit. The loss of GTPBP5 induces the specific 
activation of the translation of subunits of Complex V and disruption of its proper formation (Kotani 
et al. 2013b). Another protein of Obg family, GTP-binding protein 10 (GTPBP10), physically 
interacts with 16S rRNA and crosslinks with several proteins of mt-LSU. Due to the crucial role for 
mitoribosomal maturation, the deletion of GTPBP10 leads to the absence of the 55S monosome, 
completely inhibiting the synthesis of mtDNA-encoded proteins (Maiti et al. 2018).  
Another GTPase C4orf14 is a homolog to bacterial Mtg3 which belongs to the YqeH protein family. 
Through transiently interacting with the mt-SSU, C4orf14 recruits specific MRPs to the 28S mt-SSU. 
Therefore, knockdown of C4orf14-affected components of mt-SSU leads to decreased mitochondrial 
protein synthesis. In addition, C4orf14 is capable of binding to DNA in vitro and loss of the C4orf14 
causes a depletion of mtDNA. The association of C4orf14 with both mitochondrial translation factors 
and the mitochondrial nucleoid indicate that the 28S mt-SSU could be assembled at the mitochondrial 
nucleoid, enabling the efficiently transfer of mRNA from the nucleoid to the mitoribosome (Kotani 
et al. 2013b).   
In mammals, another GTP-binding protein, GTPBP8, with an unknown function was found. GTPBP8 
belongs to the P-loop NTPase superfamily and is a homolog to YihA in Escherichia coli (E. coli) 
(Leipe et al. 2002). The deletion of YihA in E. coli  resulted in a growth rate reduction correlating to 
decreased levels of the cell division protein FtsZ and eventually displayed filamentation morphology, 
suggesting the key function in prokaryotic cells (Dassain et al. 1999). Moreover, genetic analysis also 
suggests the Bacillus subtilis (B. subtilis) YsxC gene, the GTPBP8 homolog in B. subtilis, is essential 
for the survival of the microorganism. Loss of YsxC protein causes the accumulation of immature 
ribosomal-subunit intermediates with the absence of three ribosomal proteins, uL16, bL27 and bL36 
(Schaefer et al. 2006). Purified YsxC was also shown to bind preferentially to the 50S subunit 
ribosomes in the presence of GTP (Wicker-Planquart et al. 2008). These studies suggested that YsxC 
is required for the biogenesis of ribosomal large subunit.  
In addition to three conserved GTPases, another conserved GTP-binding protein with RNA-binding 
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activity is ERAL1, which is important for the formation of 28S mt-SSU. ERAL1 localizes in the 
mitochondrial matrix and is involved in the biogenesis of mt-SSU through binding to the 12S rRNA. 
The depletion of ERAL1 leads to a rapid decay of nascent 12S rRNA (Dennerlein, Rozanska, Wydro, 
Zofia M. A. Chrzanowska-Lightowlers, et al. 2010; Uchiumi et al. 2010).   
9.2.1.4 Other mitoribosomal assembly factors 
One of the proteins in the DUF143 family, C7orf30, participates in mt-LSU assembly via interaction 
with uL14m, and promoting its incorporation into mt-LSU (Fung et al. 2013; Rorbach, Gammage, 
and Minczuk 2012; Wanschers et al. 2012) The depletion of C7orf30 diminishes the mt-LSU level 
and decreases the formation of monosome, eventually leading to the defective in mitochondrial 
protein translation (Fung et al. 2013; Rorbach et al. 2012; Wanschers et al. 2012). The m-AAA 
protease belongs to a conserved family of membrane-bound ATP-dependent proteases. The 
component of mitochondrial ribosomal large subunit, bL32m, is a proteolytic substrate of m-AAA 
protease. The processed product of bL32m assists in its correct folding for completely importing into 
pre-ribosomal particles at the late stages of mt-LSU maturation (Nolden et al. 2005).  In addition, two 
components of mitochondrial RNA granules, G-rich sequence binding factor 1 (GRSF1) and Fas-
activated serine-threonine kinase 2 (FASTKD2), are required for the assembly of mt-LSU and mt-
SSU, respectively (Antonicka et al. 2013; Antonicka and Shoubridge 2015b; Jourdain et al. 2013).  
9.2.2 Translation  
Translation occurs by a universally conserved set of stages that can be sequentially divided into 
initiation, elongation, and termination in conjunction with recycling. Each step is fully mediated by 
various nuclear-encoded regulatory proteins. At the initiation step, mitochondrial initiation factor 3 
(IF3mt) binds to ribosomal monosomes, promoting the dissociation of mitoribosome into subunits, 
and prevents their re-association (Koc and Spremulli 2002). Then GTP-bound IF2mt facilitates the 
codon-directed placement of fMet-tRNA in the P site of the ribosomal small subunits (Liao and 
Spremulli 1990). Following this step, IF3mt and IF2mt are sequentially released for the biogenesis of 
the monosome. During the elongation step three elongation factors (EFs) assist the decoding of the 
mRNA coding sequence. EF-Tumt delivers the aminoacyl-tRNA to the monosome in a ternary 
complex with GTP. EF-Tsmt regenerates the GTP-bound form of EF-Tumt after the guanosin 
diphosphate (GDP)-bound state (Schwartzbach and Spremulli 1989). EF-G1mt catalyzes the 
coordinated movement of mRNA and tRNA during the translocation process (Bhargava, Templeton, 
and Spremulli 2004). When a stop code enters the A site, the elongation is stopped by the binding of 
mitochondrial release factor RF1mt for release of the nascent chain. Finally, the mature monosome 
become a substrate for the mitochondrial ribosome recycling factor (RRF1mt), which splits 
mitoribosome into individual subunits so that they can reenter the translation cycle (Christian and 
Spremulli 2012a; Tsuboi et al. 2009).  
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AIMS OF THE STUDY 
Quality control of mitochondrial structure and function is paramount for critical cellular processes, 
from energy production to apoptosis. Notably, numerous biological processes in mitochondria, 
including maintenance of ultrastructure, protein expression, and regulatory functions, are almost 
always carried out by proteins organized further into high-ordered structures and networks. Therefore, 
the mitochondrial proteins with unknown functions interest us to elucidate their sub-mitochondrial 
localization and biological functions. Prior to the research conducted for this thesis, it was known that 
BAR domain proteins sculpt phosphoinositide-rich membranes to generate membrane protrusion or 
invaginations. Through forming dimers with a positively charged surface, BAR domain proteins bind 
to negatively charged lipid membranes, and thus, play crucial roles for many cellular processes 
involved in membrane remodeling and dynamics such as endocytosis, cell migration, and cell division  
(Zhao et al. 2013; Zhao, Pykäläinen, and Lappalainen 2011). However, whether some BAR domain 
proteins sculpt membranes in mitochondria remains obscure. Furthermore, while great strides have 
been made in recognizing the process of mitochondrial gene expression, the precise regulation factors 
involved in the formation of mitochondrial ribosomes are poorly understood. Another novel GTP-
binding protein, GTPBP8, belongs to the P-loop NTPase superfamily. The deletion of bacterial 
homologs of GTPBP8, namely YihA in E. coli, has resulted in a growth rate reduction and 
filamentation (Dassain et al. 1999), suggesting key roles of GTPBP8 in mitochondria. To date, the 
detailed biological function of GTPBP8 in mitochondria remains to be clarified. Therefore, the aim 
of this study was to determine the biological functions of novel proteins residing in mitochondria. By 
elucidating functions of novel mitochondrial proteins, we can comprehend how mitochondrial 
activities and mitochondrial protein involved in cellular function control cell fate. This is particularly 
important in view of the pivotal roles of mitochondria in energy provision and cell signaling, 
especially in uncontrolled cancer cells. Thus, drugs can be designed to target mitochondria or some 
cancer-relevant mitochondrial proteins for efficient cancer therapy.  
Specific aims of this project included the following: 
1. Identify previously uncharacterized novel mitochondrial proteins.  
2. Examine the expression profiles of novel mitochondrial proteins in cells and mouse/rat tissues. 
Determine the sub-mitochondrial localization of novel mitochondrial proteins by cell biology 
and biochemical approaches.  
3. Elucidate the cellular function of novel mitochondrial proteins and the underlying molecular 
mechanisms.   
4. Explore whether mitochondria is a useful target for efficient cancer therapy, providing some 
experiment hints for solving current problems of cancer therapy.  
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MATERIALS AND METHODS 
Table 1. The main experimental methods applied in this study. The details of the materials, including 
antibodies, reagents and kits, and methods used in the study can be found in the corresponding articles 
and the affiliated supplementary information.  
Methods Publications 
Mammalian cell culture and transfection I, II, III 
Transfection for protein knockdown and expression I, III 
Rescue experiments I, III 
CRISPR/Cas9-mediated gene knockout I 
Immunofluorescence I, III 
APEX2 staining I 
ImmunoEM I, III 
Transmission electron microscopy I, II, III 
Electron cryotomography I 
Time-lapse image of cells I 
Fluorescence light microscopy I, II, III 
SDS-polyacrylamide gel electrophoresis I, II, III 
Blue-native polyacrylamide gel electrophoresis (BN-PAGE) I, III 
Western blotting I, II, III 
Molecular cloning and site-directed mutagenesis I, III 
DNA and RNA isolation III 
Real-time quantitative PCR III 
Production and purification of recombinant Proteins I, III 
Mitochondrial complex I and IV activity assay I 
GTPase activity assay in vitro III 
Vesical preparation I 
Membrane binding assay I 
Cell fractionation assay I, III 
Mitochondrial isolation I, III 
Proteolysis of mitochondria and alkaline extraction I, III 
Cell viability assay I, III 
Detection of mitochondrial membrane potential, ROS and ATP I, III 
Mass spectrometry III 
Measurement of cellular metabolism I, III 
Radioisotope labeling III 
Isokinetic sucrose gradient assay III 
Quantitative western blotting or coomassie stained SDS PAGE analysis  I, III 
Quantitative image analysis (EM data) I 
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Immunofluorescence, live-cell imaging and ImmunoEM 
For immunofluorescence, U2OS cells were grown on coverslips and fixed with 4% paraformaldehyde 
for 20 min, washed three times with PBS and permeabilized for 5 min with 0.1% Triton X-100 in 
PBS. For antibody staining, permeabilized cells were blocked with Dulbecco plus 0.2% BSA for 30 
min and were sequentially incubated with primary antibody and fluorescence-conjugated secondary 
antibody. Cells were mounted in Mowiol containing 2.5% wt/vol 1,4-diazabicyclo[2.2.2]octane 
(DABCO) and imaged with DM6000B microscope using Application of Suite X software using 
63x/1.4-0.60 HCX PL Apochromat objective, and brightline filters (Semrock): GFP-4050B 
(excitation, 466/40; emission, 525/50), TRITC-B (excitation, 543/22; emission, 593/40), with an 
Orca-Flash4.0 V2 scientific complementary metal-oxide semiconductor (sCMOS) camera 
(Hamamatsu Photonics). 
For live-cell imaging, U2OS cells were transfected mitochondrial matrix targeted YFP (mito-YFP) 
for 48h. Cells were re-plated on 10 μg/ml fibronectin-coated glass-bottomed dishes in complete 
DMEM medium. Put the dishes in a 37°C sample chamber with controlled 5% CO2 flow and the 
time-lapse images were acquired with 3I Marianas imaging system, equipped with an inverted 
spinning disk confocal microscope Axio Observer Z1 (Zeiss) and a Yokogawa CSU-X1 M1 confocal 
scanner (Yokogawa) and brightline filter (Semrock). A 63x/1.2 W C-Apochomat Corr WD =0.28 
M27 objective was used and all the images were acquired by a sCMOS 34 Neo camera (Andor) and 
slideBook 5.0 software. Analyses of the video frames were performed with Image Pro Plus 6.0 (Media 
Cybernetics). 
For pre-embedding immunoEM, U2OS cells were grown on coverslips and fixed with PLP fixative 
(2% formaldehyde, 0.01 M periodatem, and 0.075 M lysine-HCL in 0.075 M phosphate buffer, pH 
7.4) for 2 h (Uchiyama et al. 2002). Cells were permeabilized with 0.05% saponin and immunolabeled 
using primary antibody followed by immunostaining with Nanogold secondary antibody. Nanogold 
was silver enhanced using the HQ Silver kit for 5 min and gold toned with 0.05% gold chloride. After 
washing, the cells were further processed for embedding.  
Isolation and purification of mitochondria  
Mitochondria were isolated and purified as described previously (Frezza, Cipolat, and Scorrano 2007). 
Briefly, cells were washed in precold PBS and resuspended in homogenization buffer (10 mM Tris-
MOPS, 1 mM EGTA, and 200 mM sucrose, pH 7.4). Cell suspension was homogenized with a 
rotating Teflon potter (Potter S; Braun). Nonlysed cells were sedimented at 600 g and discarded. The 
supernatant was subsequently centrifuged at 7,000 g, and the resulting pellet was the mitochondrial 
fraction.  
Proteolysis of mitochondria and Alkaline extraction of mitochondrial proteins  
For proteolysis of mitochondria, mitochondria were subfractionated to obtain mitoplasts by using a 
phosphate swelling-shrinking method (Kang et al. 2007). Briefly, for breaking the MOM, purified 
mitochondrial pellets were suspended in swelling buffer (10 mM KH2PO4, pH 7.4) and incubated for 
20 min with gentle mixing. To keep the mitoplasts intact, mitochondria were mixed with equal 
volume of shrinking buffer (10 mM KH2PO4, pH 7.4, 32% sucrose, 30% glycerol, and 10 mM MgCl2) 
for another 20 min. The purified mitochondria and mitoplasts were suspended in homogenization 
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buffer (10 mM Tris-MOPS, 1 mM EGTA, and 200 mM sucrose, pH 7.4) and treated with 0.2 mg/ml 
proteinase K with or without the presence of 1% NP-40 for 30 min. NP-40 was used to gently 
permeabilize mitochondrial membranes to allow proteinase K to enter mitochondria. Proteinase K 
activity was quenched with 2 mM PMSF for 10 min. All steps were performed on ice. 1% SDS was 
added to solubilize mitochondrial proteins, and the samples were blotted as indicated.  
For alkaline extraction of mitochondrial proteins, the purified mitochondria were resuspended in 0.1 
M Na2CO3, pH 11, 11.5, or 12, or PBS, pH 7.4, on ice for 30 min with occasional vortex mixing and 
then centrifuged at 51,000 rpm for 30 min at 4°C using an Optima ultracentrifuge with a TLA 120 
rotor (Beckman Coulter). The membrane pellets were dissolved in Laemmli loading buffer (2% SDS, 
10% glycerol, 60 mM Tris-HCL, and 0.005% bromophenol blue). Supernatants were precipitated 
using TCA with a final concentration of 13% on ice for 30 min. After centrifugation at 20,000 g for 
30 min, pellets were washed two times with ice-cold acetone and dissolved in Laemmli loading buffer. 
The initial total mitochondria used for alkaline extraction, pellets, and supernatant were subjected to 
SDS-PAGE and Western blotting analysis.  
Blue-native PAGE 
The blue native gel electrophoresis was performed using the NativePAGETM Novex® Bis-Tris Gel 
System according to manufacturer’s protocol. Briefly, mitochondria were suspended in lysis buffer 
(50 mM Bis-Tris, 50 mM NaCl, 10% glycerol, 0,001% Ponceau S, 1.2% digitonin, 16 mM HCL, pH 
7.2) on ice for 30 min and centrifuged at 22,000g for 30 min. The supernatant was supplemented with 
0.2% Coomassie G250 dye and loaded on a 3-12% gradient NativePAGE Gel. Proteins were 
transferred to the polyvinylidene fluoride (PVDF) membrane which was subsequently incubated in 
8% acetic acid and activated with methanol.  
Measurement of cellular metabolism  
The cellular oxygen consumption rate (OCR) was measured using a Seahorse XF96e analyzer 
(Seahorse Bioscience; Agilent Technologies). The XF96 sensor cartridge was activated with 200 μl 
XF96 calibrant solution per well for 12 h at 37°C. U2OS cells were seeded onto XF96 cell culture 
microplates and change the culture medium with serum-free and bicarbonate-free DMEM 
supplemented with 10 mM glucose, 5 mM pyruvate, and 5 mM glutamine one hour before 
measurement. After incubation for 1 h at 37°C in a non-CO2 incubator, steady-state and 
postintervention analyses were performed. Respiration was assessed by injection of oligomycin (1 
μM) to inhibit the mitochondrial ATP synthase, carbonyl cyanide-p-trifluoromethoxy-
phenylhydrazone (FCCP; 1 μM) to collapse the mitochondrial membrane potential, and rotenone (1 
μM) and antimycin A (1 μM) to inhibit the respiratory chain. The OCR was measured before and 
after the addition of inhibitors at indicated times. The OCR was normalized to total protein amount 
(micrograms).  
Measurement of mitochondrial membrane potential, ROS and ATP production 
Mitochondrial membrane potential was measured using the fluorescent dye tetramethylrhodamine 
methyl ester (TMRM; T668; Thermo Fisher Scientific). U2OS cells were stained with 50 nM TMRM 
for 15 min at 37°C. Cellular superoxide anions and mitochondria superoxide were detected using 10 
μM dihydroethidium (DHE, D1168; Thermo Fisher Scientific) and 1 μM MitoSOX (M36008; 
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Molecular Probes), respectively. Cellular ATP levels were detected by an ATP determination kit 
(A22066; Thermo Fisher Scientific) according to the manufacturer’s instructions. The fluorescence 
intensity was recorded using a Varioskan LUX multimode microplate reader with SkanIt Software 
5.0 (Thermo Fisher Scientific). The excitation (ex) and emission (em) wavelength were set basing on 
instruction of each fluorescent dye with a slightly modify. TMRM: ex549nm/em580nm; DHE: 
ex510nm/em600nm; MitoSOX: ex510nm/em580nm;  
Radioisotope labeling of mitochondrial translation  
Mitochondrial protein synthesis in cultured cells was detected through metabolic labeling with [35S] 
methionine/cysteine in the presence of anisomycin to inhibit cytoplasmic ribosomes (Richter et al. 
2015). Simply, U2OS cells were washed three times with PBS and pretreated with 100 μg/ml 
anisomycin for 5 min to inhibit cytoplasmic translation. Subsequently, [35S] methionine/cysteine 
(EasyTag; PerkinElmer) was added with a final concentration of 400 μCi for pulse labeling. After 
pulse labeling for indicated time, cells were washed two times with PBS for detection or medium 
without [35S] methionine/cysteine for chase labeling. After 6 h chasing, cells were scraped and treated 
with benzonase® Nuclease (E1014, Sigma) according to the manufacturer’s instructions. The samples 
were supplemented with gel loading buffer (186-mM Tris-HCL, pH 6.7, 15% glycerol, 2% SDS, 0.5 
mg/ml bromophenol blue, and 6% β-mercaptoethanol) and loaded on a 12-20% gradient SDS-PAGE 
gel to separate samples. The gel was then dried for exposure with a phosphor screen and scanned with 
a FUJIFILM FLA-5100. Gels were rehydrated in water and Coomassie stained to confirm loading.  
Isokinetic sucrose gradient assay 
The sedimentation properties of GTPBP8 and the ribosomal proteins in sucrose gradients were 
analyzed essentially as described (Richter et al. 2015). Cells or mitochondria were lysed with 1% 
DDM lysis buffer (50 mM Tris, pH 7.2, 10 mM Mg(Ac)2, 40 mM NH4Cl, 100 mM KCl, 1% DDM, 
and 1 mM PMSF) for 20 min on ice followed by centrifugation for 20 min at 20,000 g and 4°C. The 
supernatant containing 900 μg total protein was loaded on top of a 16 ml linear 10-30% sucrose 
gradient (50 mM Tris, pH 7.2, 10 mM Mg(Ac)2, 40 mM NH4Cl, 100 mM KCl, and 1 mM PMSF) 
and centrifuged for 15 h at 4°C and 74,400 g (SW 32.1 Ti; Beckman Coulter). 24 equal volume 
fractions were collected from the top and subjected to TCA precipitation. Samples were separated by 
SDS-PAGE for immunoblotting.  
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RESULTS AND DISSCUSSION  
10. Cellular localization of FAM92A1 and GTPBP8  
10.1 Identification of novel proteins FAM92A1 and GTPBP8  
The BAR domain proteins play key roles in membrane remodeling (Zhao et al. 2013, 2011), but none 
are involved in the remodeling of mitochondrial membrane structure, especially the high curved crista  
structure. First of all, we searched for novel BAR domain protein in the conserved BAR domain 
database by NCBI combined with BLAST searches using the classical BAR domain of endophilin. 
We found an uncharacterized BAR domain protein FAM92A1, which is highly conserved among 
mammals and contains a classical BAR domain at the N-terminus (Carman and Dominguez 2018). 
We then aimed to investigate the cellular localization and function of FAM92A1, to shed light on 
whether FAM92A1 is involved in sculpting the membranes where it resides and how FAM92A1 
remodels membrane structures. In addition, because GTPases play important roles in membrane 
fission and fusion we searched for novel GTP-binding proteins by conserved GTPase domains. A 
novel GTP-binding protein 8, GTPBP8, was identified. We aimed to elucidate the subcellular 
localization and cellular function of GTPBP8.  
10.2 FAM92A1 and GTPBP8 are mitochondrial proteins   
10.2.1 Validation of commercial antibodies 
The cellular localization of FAM92A1 and GTPBP8 was examined in U2OS cells. To address the 
above questions, commercial antibodies were used to test the cellular localization of the endogenous 
FAM92A1 and GTPBP8 proteins. First, the commercial anti-FAM92A1 and anti-GTPBP8 antibodies 
were validated using Western blotting. The antigen used for generating the anti-FAM92A1 antibody 
(Cat. #HPA034760, Sigma-Aldrich) is KTIFSEFITIEMLFHGKALEVYTAAYQNIQNIDEDEDLE 
VFRNSLYAPDYSSRLDIVRANSKSPLQRSLSAKCVSGTGQEAGWAATCQTLI (FAM92A1-
Human, 181-289aa). The anti-FAM92A1 antibody displays only one 
band at approximately 29 kDa in the Western blotting of the U2OS 
cell lysates. To validate the antibody of FAM92A1, we 
overexpressed the recombinant green fluorescent protein (GFP)-
tagged full-length human FAM92A1 (1-289aa-GFP) and the mutant 
1-181aa (1-181aa-GFP). The anti-FAM92A1 antibody can recognize 
the full-length recombinant 1-289aa-GFP but not the 1-181aa-GFP 
(Figure 10). In addition, in the gene knockdown experiments, the 
specific band recognized by anti-FAM92A1 antibody was gradually 
depleted with extended time of FAM92A1 siRNA treatment (I, 
Figure 2A). Taken together, these data suggest that the commercial 
anti-FAM92A1 antibody specific recognized to the endogenous 
FAM92A1 protein. 
Figure 10. The endogenous FAM92A1 protein can be specific recognized by 
an anti-FAM92A1 antibody. Western blotting separately detected the 
overexpressed GFP-N1, 1-181aa-GFP and 1-289aa-GFP. Only the full-length 
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FAM92A1 (1-289aa-GFP) can be visualized. The mutant lacking of antigen (1-181aa-GFP) cannot be assessed. The black 
and white arrow showed endogenous FAM92A1 and the expressed GFP-tagged FAM92A1 protein, respectively. 
The anti-GTPBP8 antibody (Cat. #HPA03481, Sigma-Aldrich) was validated using GTPBP8-GFP 
and GTPBP8-myc expressed U2OS cells. The antigen used for generating the anti-GTPBP8 antibody 
is AGRLFEMPAVLERLSRYNSTSQAFAEVLRLPKQQLRKLLYPLQEVERFLAPYGRQDLHL 
RIFDPSPEDIARADNIFTATERNRIDYVSS (GTPBP8-Human 10-98aa). The anti-GTPBP8 
antibody recognized several bands in the Western blotting assay. The size of the endogenous GTPBP8 
is around 28 kDa (1-284aa). The overexpressed GTPBP8-myc in U2OS cells can also be detected by 
the anti-GTPBP8 antibody with the position a little bit higher than the endogenous GTPBP8 at around 
31 kDa (III, Figure S2). In addition, mitochondria isolated from U2OS cells were loaded on the gel 
with different mitochondrial quantities. Consistent with the results of endogenous and overexpressed 
GTPBP8-Myc, the intensity of detected band around 28 kDa was gradually enhanced with an 
increased quantity of mitochondria (III, Figure S2C). Furthermore, the band intensity around 28 kDa 
was decreased after treatment with GTPBP8 siRNA (III, Figure 2B), suggesting that the band around 
28 kDa recognized by the commercial anti-GTPBP8 antibody is the endogenous GTPBP8 protein. 
Taken together, these data suggested that both anti-FAM92A1 and anti-GTPBP8 antibodies can 
recognize the corresponding endogenous proteins. 
10.2.2 Cellular localization of FAM92A1 and GTPBP8 
The anti-FAM92A1 antibody recognized only one band in the Western blotting and our results 
showed that this antibody is very specific. Thus, we used the anti-FAM92A1 antibody to determine 
the cellular localization of FAM92A1. Due to multiple bands can be detected by anti-GTPBP8 
antibody in western blotting, except anti-GTPBP8 antibody applied for endogenous GTPBP8 
antibody, we further used the expressed GTPBP8-GFP and GTPBP8-myc to verify the cellular 
localization of GTPBP8 in U2OS cells. Fluorescence microscopy showed that both endogenous 
FAM92A1, GTPBP8 and expressed GTPBP8 (GTPBP8-GFP and GTPBP8-Myc) co-localized with 
the mitochondrial marker, MitoTracker red (I, Figure 1B) and mitochondrial outer membrane protein 
TOM20 and mitochondrial inner membrane protein COXIV (III, Figure 1A), respectively. The cell 
fractionation confirmed that the majority of the endogenous FAM92A1 (I, Figure 1C) and all of the 
endogenous GTPBP8 (III, Figure 1C and S2D) resided in the mitochondrial fraction. These data 
indicated that FAM92A1 and GTPBP8 are mitochondrial proteins.  
10.3 Sub-mitochondrial localization of FAM92A1 and GTPBP8  
Mitochondria possess two enclosed membranes with several sub-mitochondrial functional domains. 
Thus, to determine the sub-mitochondrial localization of GTPBP8 and FAM92A1, isolated 
mitochondria were treated with proteinase K in the absence or presence of detergent NP-40. 
Compared with outer membrane proteins TOM20 and TOM40, which were sensitive to proteinase K 
and degraded when treated with proteinase K, FAM92A1 and GTPBP8 were resistant to proteinase 
K digestion. After the outer membrane was disrupted by hypo-osmolar treatment, the mitoplasts were 
exposed with proteinase K. The mitochondrial intracristal space protein cytochrome C was degraded 
when mitoplasts were treated with proteinase K. In contrast to cytochrome C, GTPBP8 and 
FAM92A1 were not accessible to proteinase K, similarly to the mitochondrial inner membrane 
protein COXIV and the matrix protein HSP60. After complete solubilization of mitochondrial 
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membranes, all proteins were degraded by proteinase K. Together, these data indicated that 
FAM92A1 (I, Figure 1D) and GTPBP8 (III, Figure 1D) resided either in the inner leaflet of the 
MIM or in the matrix. To corroborate these findings, we performed immunoelectron microscopy 
using anti-FAM92A1 and anti-myc antibodies to determine the sub-mitochondrial localization of the 
endogenous FAM92A1 and expressed GTPBP8-myc, respectively. The results confirmed that both 
FAM92A1 and GTPBP8-myc localized in the matrix in close proximity to the inner membrane (I, 
Figure 1E for FAM92A1 and III, Figure 1F for GTPBP8).   
Subsequently, to examine whether FAM92A1 and GTPBP8 are bound to the MIM or soluble in the 
matrix, the isolated mitochondria were subjected to alkaline carbonate extraction with increasing pH. 
The integral MIM protein COXIV, the peripheral MIM protein uL16m and the soluble matrix protein 
HSP60 served as controls. Interestingly, FAM92A1was found predominately in the pellet/membrane 
fraction but was released to the supernatant with increasing pH, indicating that FAM92A1 is a 
membrane-bound but not an integral membrane protein (I, Figure 1G). In contrast to FAM92A1, the 
membrane binding ability of GTPBP8 was relatively weaker, and the majority of GTPBP8 protein 
was recovered in the supernatant fraction at pH 11, displaying a similar pattern with the 
mitoribosomal large subunit protein uL16m (III, Figure 1E). Taken together, our data revealed that 
FAM92A1 and GTPBP8 are mitochondrial proteins peripherally associated with the MIM.  
10.4 Mitochondrial import of FAM92A1 and GTPBP8 
Most nuclear-encoded mitochondrial proteins are synthesized in the cytosol and imported into 
mitochondria by a cleavable mitochondrial targeting presequence (Bolender et al. 2008; Neupert and 
Herrmann 2007). The mitochondrial import presequence is classically an amphipathic helix that is 
15-70 residues in length and enriched in the positively charged cluster on one side of the helix 
(Alberts et al. 2002; Bolender et al. 2008).To address whether FAM92A1 and GTPBP8 possess such 
mitochondrial targeting sequence, we analyzed their amino acid sequences and performed the online 
mitochondrial import prediction algorithms. The online prediction results indicate a clear 
mitochondrial import sequence in GTPBP8 (IMPI and TargetP score is 1 and 0.815, respectively.  
http://mitominer.mrc-mbu.cam.ac.uk/release4.0/report.do?id=1021783&trail=%7c1021783). 
Despite a lower possibility of mitochondrial import sequence for FAM92A1 predicted by the online 
program, FAM92A1 harbors a characteristic mitochondrial import presequence at the N-terminus, 
consisting of an alternating pattern of hydrophobic and positively charged amino acids, exhibiting a 
high number of arginine and lysine, with only a few negatively charged residues (Figure 11). 
FAM92A1_Human MMRRTLENRNAQTKQLQTAVSNVEKHFGELCQIFAAYVRKTARLRDKADLLVNEINAYAA  60 
FAM92A1_Human TETPHLKLGLMNFADEFAKLQDYRQAEVERLEAKVVEPLKTYGTIVKMKRDDLKATLTAR  120 
FAM92A1_Human NREAKQLTQLERTRQRNPSDRHVISQAETELQRAAMDASRTSRHLEETINNFERQKMKDI  180 
FAM92A1_Human KTIFSEFITIEMLFHGKALEVYTAAYQNIQNIDEDEDLEVFRNSLYAPDYSSRLDIVRAN  240 
FAM92A1_Human SKSPLQRSLSAKCVSGTGQVSTCRLRKDQQAEDDEDDELDVTEEENFLK             289 
GTPBP8_Human    MAAPGLRLGAGRLFEMPAVLERLSRYNSTSQAFAEVLRLPKQQLRKLLYPLQEVERFLAP  60 
GTPBP8_Human    YGRQDLHLRIFDPSPEDIARADNIFTATERNRIDYVSSAVRIDHAPDLPRPEVCFIGRSN  120 
GTPBP8_Human    VGKSSLIKALFSLAPEVEVRVSKKPGHTKKMNFFKVGKHFTVVDMPGYGFRAPEDFVDMV  180 
GTPBP8_Human    ETYLKERRNLKRTFLLVDSVVGIQKTDNIAIEMCEEFALPYVIVLTKIDKSSKGHLLKQV  240 
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GTPBP8_Human    LQIQKFVNMKTQGCFPQLFPVSAVTFSGIHLLRCFIASVTGSLD                  284 
Figure 11.  Sequence information of human FAM92A1 and GTPBP8. The N-terminal putative mitochondrial 
targeting sequences were shown in blue. The positively charged amino acids and hydrophobic amino acids were indicated 
with red and green, respectively.  
To determine the sequence elements required for mitochondrial targeting, the N-terminal 47 amino 
acids (47aa) of FAM92A1 and 46 amino acids (46aa) of GTPBP8 were linked to the GFP (I, Figure 
1H for FAM92A1 and III, Figure 1B for GTPBP8). Transient expression of these constructs in 
U2OS cells showed an unambiguous mitochondrial localization. In contrast, FAM92A1 and GTPBP8 
lacking the N-terminal presequence displayed a cytosolic localization (I, Figure 1I for FAM92A1 
and III, Figure 1G for GTPBP8), demonstrating that the N-terminal peptides are essential for the 
import of FAM92A1 and GTPBP8 into mitochondria. The mitochondrial targeting peptides usually 
form amphipathic alpha helices, allowing the proteins to interact with membranes. To identify 
whether the putative presequence of FAM92A1 1-47aa and GTPBP8 1-46aa generates a helical 
structure, the helical wheel projection diagrams for both peptides were executed 
using Heliquest software (Gautier et al. 2008). The wheel projections strongly suggested the 
formation of an alpha helix structure as shown in Figure 12. Taken together, the N-terminus of both 
proteins are essential for mitochondrial import. 
 
Figure 12. Helical wheel projections of putative mitochondrial targeting sequence. Helical projections of α-helices 
were obtained using the HeliQuest web server (http://heliquest.ipmc.cnrs.fr/). Residues are color-coded in blue (K, R) for 
positively and red (D, E) for negatively charged residues. Non-polar residues are shown in yellow or gray and others in 
purple, light blue, or light pink. The arrow shows the hydrophobic moment.  
In addition, the putative molecular weight of FAM92A1 and GTPBP8 is around 32 kDa and 31 kDa, 
respectively. However, the actual detected molecular weight of FAM92A1 and GTPBP8 in U2OS 
cells were at 29 kDa and 28 kDa, respectively, suggesting that the N-terminal presequence of both 
proteins are cleaved off after mitochondrial import. 
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11. Function characterization of FAM92A1 and GTPBP8   
11.1 Depletion of FAM92A1 and GTPBP8 results in reduced cell proliferation  
To gain insight into the function of FAM92A1, the CRISPR/Cas9-based method was applied to 
knockout FAM92A1 protein. However, knockout of FAM92A1 was lethal and no stable clone was 
acquired, suggesting the essential role of FAM92A1 for cell survival. Therefore, small interfering 
RNA (siRNA) was applied to knockdown the endogenous FAM92A1 protein in U2OS cells. The 
effectiveness of protein silencing was assessed after treatment with siRNA at indicated times (I, 
Figure 2A). The FAM92A1 level was gradually decreased with extended time of siRNA treatment, 
suggesting that FAM92A1 siRNA was specifically targeted to FAM92A1. To investigate the function 
of GTPBP8, the GTPBP8 siRNA pool was applied to knockdown endogenous GTPBP8 protein. The 
result showed two siRNA strands (2# and 4#) induced at least 90% reduction of GTPBP8 at 
transcription level (III, Figure 2A). Therefore, the siRNA 4# was applied in further studies. After 
treatment with siRNA 4# for 5 days, the endogenous GTPBP8 was efficiently depleted in U2OS cells 
(III, Figure 2B). Cell proliferation after the siRNA treatment was evaluated using Thiazolyl Blue 
Tetrazolium Bromide (MTT) assay, showing that loss of FAM92A1 and GTPBP8 resulted in low cell 
proliferation rate compared with control cells (I, Figure 2B for FAM92A1 and III, Figure 2C for 
GTPBP8). The inhibited cell growth after depletion of FAM92A1 and GTPBP8 indicates that 
FAM92A1 and GTPBP8 are required for cell survival. 
11.2 Depletion of FAM92A1 and GTPBP8 increases oxidative stress in cells 
The maintenance of oxygen homeostasis in mammalian cells is fundamental for the survival of the 
organism. Mitochondria have been validated as the main generator of reactive oxygen species (ROS). 
The excessive oxidant stress burden triggers the opening of mitochondrial channels, leading to the 
simultaneous collapse of the mitochondrial membrane potential, which finally causes cell death 
through apoptosis (Zorov et al. 2000; Zorov, Juhaszova, and Sollott 2006). Therefore, to determine 
the molecular mechanisms involved in the reduced cell growth ability, the mitochondria generated 
ROS was assessed using a mitochondrial targeted fluorescent superoxide sensor (MitoSox). 
Compared with control cells, FAM92A1 and GTPBP8 depletion caused a significant increase in 
oxidative stress in mitochondria (I, Figure 2D for FAM92A1 and III, Figure 2D for GTPBP8). 
Furthermore, the mitochondrial membrane potential was simultaneously diminished in FAM92A1 
defective cells(I, Figure 2C). These results suggest that the cell growth arrest caused by depletion of 
FAM92A1 and GTPBP8 is attributed to different mechanisms.   
11.3 Loss of FAM92A1 and GTPBP8 impairs mitochondrial respiration  
Through protonic circuits, mitochondria have the capability to couple electron transportation and 
oxidative phosphorylation, generating maximal ATP for normal mammalian cell activity (Steinberg-
Yfrach et al. 1998). Electron transfer from respiratory chain substrates to molecular oxygen results in 
the vectorial translocation of protons, and this protonic energy is utilized for ATP synthesis, ion 
translocation, and mitochondrial protein import (Hatefi 1985). Thus, OCR and ATP level are widely 
applied to evaluate mitochondrial respiration ability. In our studies, OCR was measured to examine 
the effects of FAM92A1 and GTPBP8 depletion on mitochondrial respiration. Strikingly, silencing 
of FAM92A1 and GTPBP8 induced a drastic drop in rates of oxygen consumption, indicating 
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significantly diminished mitochondrial respiratory capacity (I, Figure 2F for FAM92A1 and III, 
Figure 2F for GTPBP8). Consistent with this, the total cellular ATP levels were decreased after 
depletion of FAM92A1 and GTPBP8 in U2OS cells (I, Figure 2H for FAM92A1 and III, Figure 
2H for GTPBP8). 
11.4 Depletion of FAM92A1 and GTPBP8 leads to aberrant assembly of respiratory chain 
complexes  
The respiratory chain complexes consist of five heteromeric complexes, complex I, II, III, IV, and V. 
Except for complex II, several core subunits of the respiratory chain complexes are encoded by 
mtDNA. Our data revealed that mitochondrial respiration and cellular ATP level were decreased after 
depletion of FAM92A1 or GTPBP8. We wondered whether depletion of FAM92A1 or GTPBP8 
would affect the assembly of respiratory complexes. To address this question, BN-PAGE followed 
by immunoblotting analysis was performed to examine the assembly of respiratory chain complexes 
in isolated mitochondria after knockdown FAM92A1 and GTPBP8. The results showed that depletion 
of FAM92A1 predominantly reduced the formation of complexes I and IV (I, Figure 2I) as well as 
the corresponding enzyme activity (I, Figure 2J). In contrast, the assembly of respiratory chain 
complexes I, III, IV, and V were moderately decreased after depletion of GTPBP8 (III, Figure 2I). 
However, the assembly of nuclear-encoded complex II was not significantly affected by depletion of 
GTPBP8, suggesting that the aberrant assembly of the respiratory chain complexes containing 
mtDNA-encoded subunits may be related to the steady-state level of mtDNA-encoded subunits.  
11.5 Aberrant level of respiratory complexes in FAM92A1 and GTPBP8 depletion cells was 
caused by different mechanisms  
To determine the factors causing the abnormal respiratory complexes, the mtDNA copy number and 
steady-state protein level of subunits from both nuclear-encoded and mtDNA-encoded subunits were 
measured. The results revealed that the protein levels tested from both genomes were unaffected by 
FMA92A1 knockdown (I, Figure 2K), indicating that defects in the assembly of complex I and IV 
may be attributed to abnormal assembly processes or poor stability of complexes, but not to decreased 
expression level of protein subunits. In GTPBP8-depleted cells, the steady-state level of mtDNA-
encoded proteins were significantly decreased, while the nuclear-encoded protein levels were 
unaffected (III, Figure 3A). These data imply that the defects of respiratory complexes assembly in 
GTPBP8-depleted cells were caused by the diminished expression levels of mtDNA-encoded 
subunits. 
12. FAM92A1 regulates mitochondrial morphology and inner membrane architecture  
12.1 FAM92A1 depletion induces abnormal mitochondrial morphology and impairs 
mitochondrial dynamics 
Mitochondrial function is closely linked to organelle morphology and structure. Therefore, 
mitochondrial morphology and dynamics were examined after downregulation of FAM92A1 using 
fluorescence microscopy and living cell imaging, respectively. The results revealed that depletion of 
FAM92A1 induced dramatic changes in mitochondrial morphology with the appearance of abnormal 
spherical and fragmented mitochondria, in contrast to the tubular mitochondrial network in control 
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cells (I, Figure 3A). Furthermore, loss of FAM92A1 obviously impaired mitochondrial dynamics. 
The bleb-shaped mitochondria displayed clear defects in mitochondrial fusion and fission (I, Videos 
1 and 2).  
12.2 Loss of FAM92A1 causes aberrant mitochondrial inner membrane architecture  
To further assess the changes in mitochondrial morphology, the mitochondrial ultrastructure was 
examined using transmission electron microscopy. Interestingly, the results showed that FAM92A1 
depletion drastically changed the mitochondrial inner membrane architecture, without apparent 
effects on the mitochondrial outer membrane. The majority of mitochondria in FAM92A1-
knockdown cells had less membrane invagination and membrane remodeling than the elongated 
invaginations presenting in control cells. Some mitochondria in FAM92A1-knockdown cells were 
completely devoid of membrane invaginations (I, Figure 3C and 3D). These data indicate that 
FAM92A1 is involved in the maintenance of mitochondrial inner membrane architecture.  
The mitochondrial inner membrane consists of two domains, the inner boundary membrane and the 
crista membrane, which are connected by crista junctions (Frank et al. 2001; von der Malsburg et al. 
2011). To further determine which ultrastructure was directly linked to FAM92A1, the width of the 
crista junction opening and the length of crista were quantified based on images obtained in electron 
microscopy. Interestingly, depletion of FAM92A1 profoundly reduced the length of crista without 
significant effects on the morphology of crista junction (I, Figure 3E and 3H).   
Despite the majority of crista junctions being unaffected, some were widened in FAM92A1 depleted 
cells compared with control cells (I, Figures S2K). Crista junctions are highly curved tubular 
openings that separate crista membrane invaginations from the surrounding boundary membranes. 
Extensive studies showed that the MICOS complex is required for the biogenesis and maintenance 
of mitochondrial crista junction as well as proper tethering of the two mitochondrial membranes 
(Barbot et al. 2015; Rabl et al. 2009). In human mitochondria, the MICOS complex is composed of 
six subunits forming a large complex around the crista junction. Depletion of some subunits reduces 
the formation of the MICOS complex and eventually leads to aberrant crista morphology (Olichon et 
al. 2003). To examine whether depletion of FAM92A1 affects the MICOS complex, the level of 
MICOS complex was determined using BN-PAGE. The results showed that the abundance of MICOS 
complex was decreased in FAM92A1 depleted cells relative to control cells (I, Figure S2L). Thus, 
we speculate that in FAM92A1 depleted cells the loss of membrane invagination caused by 
FAM92A1 depletion affects the stability of MICOS complex, causing degradation of the MICOS 
complex. However, in already formed membrane invaginations, the MICOS complex retained its 
ability to maintain normal crista junction opening.  
Taken together, our data revealed that FAM92A1 is essential for maintaining mitochondrial 
morphology and inner membrane ultrastructure. Loss of FAM92A1 impaired mitochondrial inner 
membrane architecture, which led to defects in the assembly or stability of the respiratory and MICOS 
complexes.  
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13. FAM92A1 binds to negatively charged phospholipids generating positive membrane 
curvature 
13.1 FAM92A1 forms dimers and binds mitochondrial membranes  
The BAR domain superfamily proteins are widely known for their involvement in membrane 
remodeling in various cellular pathways ranging from endocytic vesicle and tubule formation to cell 
migration and neuron morphogenesis (Dawson et al. 2001; Dharmalingam et al. 2009; Ho et al. 2004; 
Kim et al. 2008; Krugmann, Jordens, and Gevaert 2001). Depletion of FAM92A1 caused profound 
changes in mitochondrial inner membrane ultrastructure. Thus, we aim to examine whether 
FAM92A1 is capable of binding and sculpting the mitochondrial membrane.  
To study the roles of BAR domain in membrane binding, a BAR domain construct without the C-
terminus of FMA92A1 (FAM92A1 BAR domain) was constructed (I, Figure 4A).  The purified 
FAM92A1 BAR domain protein exists mainly as dimers with a few oligomers, displaying the 
canonical character of the BAR domains (Gallop and McMahon 2015; Mim et al. 2012) (I, Figure 
4B). Compared with full-length protein, the BAR domain mutant displayed a reduced membrane 
binding affinity to both the MOM and MIM in vesicle co-sedimentation assays (I, Figure 4C). In 
addition, a construct without the N-terminal putative mitochondrial targeting sequences named 
FAM92A1∆1-40aa was cloned for mimicking the endogenous FAM92A1 (I, Figure 4A). The results 
revealed that FAM92A1Δ1-40aa preserved membrane binding ability to the MOM and MIM, but with 
a lower affinity than the full-length protein (I, Figure 4C).  
13.2 FAM92A1 preferentially binds to negatively charged phospholipids 
To address the lipid-binding specificity of FAM92A1, vesicles containing different lipid 
compositions were used in membrane binding assays. The full-length FAM92A1 and mutants bound 
to the phosphatidylcholine (PC): phosphatidylethanolamine (PE) membranes. Interestingly, the 
negatively charged phospholipids, phosphatidylinositol 4, 5-bisphosphate (PI(4,5)P2) or cardiolipin 
significantly augmented the membrane binding ability of both full-length FAM92A1 and mutants (I, 
Figure 4D), suggesting that FAM92A1 preferentially binds to the negatively charged lipids. PC and 
PE are the major phospholipid classes in eukaryotic mitochondria, but the main difference of lipid 
composition between the MOM and MIM is the ratio of PI and cardiolipin. PI is present at large 
amount in the MOM and cardiolipin in enriched in MIM with 18% (Horvath and Daum 2013; WATT 
et al. 2002). Thus, the full-length FAM92A1 and mutants showed a similar binding ability to vesicles 
containing phospholipid compositions of the MOM and MIM. These data verified that FAM92A1 
binds to PI(4,5)P2 and cardiolipin with a similar affinity, as shown in I, Figure 4C. This finding is in 
line with the characteristic binding preference for negatively charged phospholipids shared by all 
BAR domain proteins (McMahon and Boucrot 2015).  
13.3 FAM92A1 sculpts membranes into tubular structure 
Having demonstrated that FAM92A1 binds to mitochondrial model membrane, we asked whether 
FAM92A1, like other BAR domain proteins, can directly sculpt the membrane structure. Strikingly, 
the full-length FAM92A1 and its BAR domain transformed spherical liposome into narrow tubule (I, 
Figure 4F), suggesting that FAM92A1 possesses membrane-remodeling activity by generating 
positive membrane curvature. Similar to the diameter of membrane tubule induced by classical BAR 
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domain proteins, the average diameter of tubules sculpted by FAM92A1 full-length and BAR domain 
proteins was around 32 nm and 34 nm, respectively (I, Figure 4H). Interestingly, different from the 
wild-type and BAR domain proteins, the diameter of membrane tubule generated by FAM92A1Δ1-
40aa, a mutant protein with the N-terminal 40 amino acids cleaved off, were narrower than those 
sculpted by the full-length and BAR domain proteins. The average diameter of tubule generated by 
FAM92A1Δ1-40aa was around 20 nm (I, Figure 4H).  A possible reason for the narrow diameter is 
that membrane insertion of the N-terminus of full-length FAM92A1 could change the spontaneous 
membrane curvature, thus regulating the diameter of membrane tubule (Boucrot et al. 2012; Campelo, 
McMahon, and Kozlov 2008; Gallop et al. 2006; Saarikangas et al. 2009).  
Taken together, these results reveal that FAM92A1 displays membrane-remodeling activity by 
interacting with the mitochondrial membrane and generating positive membrane curvature, indicating 
the key function of FAM92A1 in regulating mitochondrial membrane ultrastructure. 
14. Membrane binding interface of FAM92A1  
Numerous studies have shown that negatively charged phospholipids produce a negative electrostatic 
potential, which attracts clusters of positively charged residues on proteins. These electrostatic 
interactions mediate the anchor of proteins to lipid membrane (Aponte-Santamaria et al. 2012; 
Mclaughlin 2005; Zimmerberg and McLaughlin 2004). As an important factor in membrane-
remodeling processes, the BAR domain superfamily has a membrane binding interface on which 
clusters of positively charged amino acids are positioned to interact with negatively charged 
phospholipid headgroups of lipid membranes (Frost et al. 2008). In Drosophila, the BAR domain 
protein amphiphysin binds to highly curved negatively charged membranes and drives membrane 
curvature through its N-terminal amphipathic helix (Arkhipov, Yin, and Schulten 2009; Peter et al. 
2004). Mutation of positively charged residues (lysine and arginine) to negatively charged residues 
reduced the membrane binding affinity of amphiphysin and inhibited tubulation of liposomes in vitro 
(Zimmerberg and McLaughlin 2004).  
Similar to the classical BAR domain proteins, FAM92A1 preferentially interacted with the negatively 
charged phospholipids (I, Figure 4D), and thus, we asked whether FMA92A1 possesses positively 
charged clusters that mediate the membrane association. Sequence analysis found FAM92A1 has 
seven possible positively charged clusters and to examine whether these clusters are involved in 
membrane interaction, we mutated the positively charged amino acids arginine (R) and lysine (K) to 
alanine (A) (I, Figure 5A). All mutants were purified for the membrane binding and tubulation assays. 
As shown in Figure 5B of part I, three mutants, Mut3, Mut5, and Mut7, had significantly impaired 
lipid binding activity compared with the wild-type FAM92A1, suggesting that these three positively 
charged clusters are involved in the formation of interface when interact with membrane. Furthermore, 
loss of membrane binding ability profoundly reduced the membrane remodeling activity (I, Figure 
5C and 5D). Taken together, these data demonstrate that these three positively charged clusters, two 
residing in the BAR domain module and one at the C-terminal region, are the FAM92A1-membrane 
association interface.    
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15. Cellular function of GTPBP8 
15.1 GTPBP8 depletion causes defects in mitochondrial translation  
Similar to the nuclear-encoded gene expression process, the process of mtDNA-encoded gene 
expression can be regulated at the levels of mtDNA stability, transcription, and translation (Christian 
and Spremulli 2012b; Mai, Chrzanowska-Lightowlers, and Lightowlers 2017; Schatz and Mason 
2003). To elucidate the processes involved in the reduced level of mitochondrial-encoded proteins, 
mtDNA stability was assessed by measuring its abundance in control and GTPBP8-deficient cells 
using Real-time quantitative PCR (RT-qPCR). As shown in Figure 3C of Study III, after 
normalization to the β-globin gene, no significant differences in mtDNA level between the GTPBP8-
deficient cells and control cells were found. Moreover, the levels of the mtDNA-encoded mRNA 
(III, Figure 3B) and rRNA (III, Figure 6D) were unaffected by depletion of GTPBP8. These data 
suggest that the reduction of mtDNA-encoded protein abundance was attributed to the mitochondrial 
translation process, not to mtDNA or RNA levels.  
Thus, pulse-labeling experiments were applied to detect the synthesis rate of mtDNA-encoded 
proteins. After metabolically pulse-labeled with [35S] methionine/cysteine in the presence of 
anisomycin, a cytosolic protein synthesis inhibitor, the results showed a clear synthesis defect for the 
majority of mitochondrial polypeptides in GTPBP8-knockdown cells compared with control cells 
(III, Figure 3D). Together, these data suggest that GTPBP8 plays a role in the mitochondrial 
translation process. 
15.2 GTPBP8 specifically interacts with the large subunit of human mitoribosomes 
Mammalian mitoribosome is a complex molecular machinery that sediments as 55S particles, 
comprising a 28S mt-SSU and a 39S mt-LSU (Christian and Spremulli 2012a; O’Brien, O’Brien, and 
Norman 2005). Similar to cytosolic ribosomes which are responsible for the synthesis of nuclear-
encoded proteins, mitochondrial ribosome is responsible for the synthesis of 13 mtDNA-encoded 
proteins. Mammalian mitochondrial translation includes initiation, elongation, termination, and 
ribosome recycling (Mai et al. 2017). GTPBP8 shares sequence homology with the YsxC protein, 
which is associated with the assembly of the large subunit of the bacterial ribosome (Ruzheinikov et 
al. 2004; Schaefer et al. 2006; Wicker-Planquart et al. 2008). Thus, to investigate whether the human 
homolog GTPBP8 plays a similar role in mitochondrial translation, the association of GTPBP8 with 
the large subunit of human mitoribosomes was examined by using sucrose gradient sedimentation. 
The mitochondrial lysates were separated on 10-30% continuously sucrose gradients and the results 
showed that GTPBP8 co-sedimented with mt-LSU proteins. Incubation of the mitochondrial lysates 
with RNase A, which partially disrupts mitoribosomal integrity prior to loading the sucrose gradient, 
resulted in GTPBP8 sedimenting in the lighter fractions (III, Figure 4B). These results suggest that 
GTPBP8 is associated with the mitoribosomal large subunit, which may play a role in its assembly 
and/or stability. More experiments are required to examine whether GTPBP8 is involved in 
facilitating assembly of the mitoribosomal large subunit and even its interaction partners.   
15.3 GTPBP8 deletion causes abnormal accumulation of mt-LSU and reduction of mature 
mitoribosomes  
Besides the 13 mtDNA-encoded proteins, mtDNA also encodes 12S rRNA and 16S rRNA (Greber 
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and Ban 2016).  To determine whether the low abundance of mtDNA-encoded mitochondrial proteins 
were caused by the instability or the degradation of rRNA, the transcriptional level of 12S and 16S 
rRNA was examined with RT-qPCR. The results showed no obvious change of rRNA profile in 
GTPBP8-deficient cells in comparison with control cells (III, Figure 6D). To examine whether the 
translation deficiency was caused by the defects in the process of mitoribosomal biogenesis, the 
gradient sedimentation was applied to analyze the profile of mitoribosomes. The results showed an 
aberrant profile of mt-LSU in GTPBP8-depleted cells displaying with subunits of mt-LSU (uL11m, 
and uL16m), but no marked change in the profile of mt-SSU, except for a decreased level of 
monosomes (III, Figure 7A), suggesting that loss of GTPBP8 impaired the assembly process of 
mitoribosomal large subunit. Collectively, our findings uncover the cellular role of GTPBP8 in 
regulation of mitoribosomal biogenesis.  
16. Prickly nanoparticles efficiently inhibit malignant growth of cancer cells via 
mechanical damage to mitochondria  
Cancer is a complex group of diseases and a leading cause of death worldwide. Despite abundant 
efforts to find a cure, cancer remains a challenge for modern medicine and many patients continue to 
suffer from the disease. The field of nanomedicine uses nano-sized tools for the diagnosis, prevention, 
and treatment of diseases as cancer. In the past several decades, more and more nanoparticles have 
been synthesized to combat cancer. Nanoparticles are often used as a drug delivery vehicle, 
selectively delivering drugs to the corresponding cancer tissue (Ferrari 2005). Recently, several 
studies have synthesized nanoparticles that have led to cancer cell death in the absence of any 
anticancer drug (Guo et al. 2015; Lukianova-Hleb et al. 2016). For instance, plasmonic nanobubbles 
can kill cancer cells through laser-induced photothermal therapy (Lukianova-Hleb et al. 2016). 
One of our collaboration studies designed and synthesized prickly Zn-CuO nanoparticles (prickly 
NPs) for anticancer treatment. Prickly@SpAcDX-PEG-VD1142 profoundly inhibit cell viability of 
hypoxia MCF7 cells (II, Figure 4).  After escaping from the endosome, prickly NPs mainly target 
and accumulate in mitochondria (II, Figure 6). The accumulation of prickly NPs in mitochondria 
damages mitochondrial membranes and leads to obvious changes in mitochondrial networks, 
displaying a swollen and fragmented structure, not the classical tubular structure (II, Figure 7). This 
physical disruption eventually activates apoptosis and causes cell death (II, Figure 8). Taken together, 
mitochondria are promising targets for cancer therapy.  
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FINAL REMARKS AND FUTURE PERSPECTIVES 
This work systematically elucidated the sub-mitochondrial localization, mitochondrial import and 
biological functions of two novel mitochondrial proteins using the combined approaches of 
biochemistry, cell biology and molecular biology. Through studying the function of these proteins, 
we noticed that the normal mitochondrial morphology, function, and dynamics are essential for cell 
homeostasis. Dysfunction of essential mitochondrial proteins is linked to many human diseases. A 
previous study found that high expression of FAM92A1 accelerates cell proliferation and 
tumorigenesis, highlighting FAM92A1 as a potential oncogene  (Liang et al. 2009). However, how 
FMA92A1 modifies the cell cycle and the molecular mechanism underlying tumorigenesis were 
poorly understood.  In addition, full-length FAM92A1 protein contains one BAR domain at the N-
terminus and a short C-terminus (I, Figure S1A). The classic BAR domain proteins sculpt membrane 
remodeling with actin filaments that function in endocytic pathways and filopodia formation (Ahmed 
et al. 2010).  
Different from the classic BAR domain proteins, FAM92A1 localizes to the mitochondrial inner 
membrane facing the matrix. The cell growth arrest of FMA92A1-depleted cells was caused by 
impairment of mitochondrial ultrastructure. Disruption of the mitochondrial inner membrane 
ultrastructure, which is the site for the oxidative phosphorylation complexes, affects the complex 
assembly, electron transportation and ATP production, resulting in cell growth arrest. Whether 
FAM92A1 interacts with other mitochondrial proteins that sculpt the mitochondrial membrane is 
unknown. Light should also be shed on how the MICOS complex is reduced in the FAM92A1-
depleted cells. 
In addition, disturbance of the mitochondrial membrane structure through physical methods, such as 
prickly NPs, caused the release of pro-apoptotic proteins from the intracristal spaces to cytosols. 
Release of pro-apoptotic proteins and activation of apoptotic proteins, a classical mitochondrial- 
mediated apoptotic pathway, caused cancer cell death.  
Mitochondrial structure is important for cell activity and energy generation also controls the cell fate. 
The assembly of oxidative complexes maintains cell energy requirements. Thirteen mitochondrial- 
encoded proteins are essential subunits of all OXPHOS complexes, except complex II. Therefore, 
any process affecting the synthesis of mtDNA-encoded proteins can induce energy shortage. In our 
study, GTP-binding protein 8 was associated with the mitochondrial ribosomal large subunit. Loss of 
GTPBP8 caused an aberrant profile of large subunits and also reduced the level of monosomes. 
Abnormal assembly of mitochondrial ribosomes caused by depletion of GTPBP8 inhibits the 
synthesis of mitochondrial-encoded proteins, thus leading to mild defects in assembly of OXPHOS 
complexes. These defects reduced mitochondrial respiration and ATP production. In summary, 
elucidating the molecular basis of mitochondrial proteins is crucial for understanding mitochondrial 
structure and function.  
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